The Return of Biological Race? Regulating Race and Genetics Through Administrative Agency Race Impact Assessments by Obasogie, Osagie K.
University of California, Hastings College of the Law
UC Hastings Scholarship Repository
Faculty Scholarship
2012
The Return of Biological Race? Regulating Race
and Genetics Through Administrative Agency
Race Impact Assessments
Osagie K. Obasogie
UC Hastings College of the Law, obasogieo@uchastings.edu
Follow this and additional works at: http://repository.uchastings.edu/faculty_scholarship
This Article is brought to you for free and open access by UC Hastings Scholarship Repository. It has been accepted for inclusion in Faculty Scholarship
by an authorized administrator of UC Hastings Scholarship Repository. For more information, please contact marcusc@uchastings.edu.
Recommended Citation
Osagie K. Obasogie, The Return of Biological Race? Regulating Race and Genetics Through Administrative Agency Race Impact Assessments,
22 S. Cal. Interdisc. L.J. 1 (2012).
Available at: http://repository.uchastings.edu/faculty_scholarship/1361




THE RETURN OF BIOLOGICAL RACE? 
REGULATING INNOVATIONS IN RACE 
AND GENETICS THROUGH 
ADMINISTRATIVE AGENCY RACE 
IMPACT ASSESSMENTS 
OSAGIE K. OBASOGIE* 
I. INTRODUCTION 
In April 2011, I published an article in Slate1 that commented on the 
new Dietary Guidelines released by the Department of Agriculture and 
Department of Health and Human Services.2 These guidelines made several 
recommendations with the admirable purpose of encouraging Americans to 
take bold steps to improve their health, such as eating smaller portions and 
consuming more fruits and vegetables.3 Yet one of the guidelines’ “Key 
Recommendations” stood out: “Reduce daily sodium intake to less than 
2,300 milligrams (mg) and further reduce intake to 1,500 mg among 
 
 * Associate Professor of Law, University of California, Hastings College of the Law with a 
joint appointment at the University of California, San Francisco, Department of Social and Behavioral 
Sciences; Senior Fellow, Center for Genetics and Society. B.A. 1999, Yale University; J.D. 2002, 
Columbia Law School; Ph.D. 2008, University of California, Berkeley. Portions of this Article were 
first developed for and appear in a report commissioned by the Center for Genetics and Society entitled 
Playing the Gene Card? A Report on Race and Human Biotechnology (2009), and also appear in Osagie 
K. Obasogie, Race, Genetics, and the Regulatory Need for Race Impact Assessments, in RACE AND THE 
GENETIC REVOLUTION: SCIENCE, MYTH, AND CULTURE (Sheldon Krimsky & Kathleen Sloan eds. 
2011); the latter is an edited excerpt of the former. Other short edited excerpts of the report also appear 
in Osagie K. Obasogie, Return of the Race Myth, NEW SCIENTIST (July 4, 2009) and Osagie K. 
Obasogie, The Color of Our Genes: Balancing the Promise and Risks of Racial Categories in Human 
Biotechnology, SCIENCE PROGRESS, June 15, 2009. Marcy Darnovsky, Lisa Eckstein, Lisa Ikemoto, 
Richard Hayes, Jonathan Kahn, Kimani Paul-Emile, Dorit Reiss, Jesse Reynolds, Reuel Schiller, Jodi 
Short, and Pete Shanks provided invaluable comments on earlier versions of this work. 
1.  Osagie K. Obasogie, Black Salt: Should the Government Single Out African-Americans for 
Low Sodium Diets?, SLATE (Apr. 18, 2011, 3:07 PM), http://www.slate.com/id/2291513. 
2.  See U.S. DEP’T OF AGRIC. & DEP’T OF HEALTH & HUMAN SERVS., DIETARY GUIDELINES 
FOR AMERICANS, 2010 (2010), available at 
http://www.cnpp.usda.gov/Publications/DietaryGuidelines/2010/PolicyDoc/PolicyDoc.pdf [hereinafter 
DIETARY GUIDELINES FOR AMERICANS]. 
3.  Id. at viii–xi. 
OBASOGIE FINAL V3 2/26/2013  1:33 PM 
2 Southern California Interdisciplinary Law Journal  [Vol. 22:1 
 
persons who are 51 and older and those of any age who are African 
American or have hypertension, diabetes, or chronic kidney disease.”4 
There are certainly prudent medical reasons why older individuals and 
those with preexisting conditions should consume less salt.5 But, should 
this apply to all Black people? In the Slate article, I examined the scant 
support for treating race as a biological risk factor and the overwhelming 
evidence suggesting that social determinants of health6—poverty, stress 
linked to discrimination, and lack of access to healthy food in urban 
environments, among other factors—may better explain Blacks’ higher 
rates of hypertension and other sodium-related chronic diseases.7 Although 
I expected this perspective to generate pushback in the online comments 
section, the Slate article elicited something unusual and unexpected: 
interest from a White supremacist website.8 White-Pride.org reposted the 
article in its entirety, alongside articles titled Blacks Made Up Majority of 
All Serial Killers Last Decade; Obama Spent March Obsessed with 
Basketball, Not Learning About Who He Was Bombing; and Obama “Birth 
Certificate” Contains Adobe Illustrator Editing Data. It initially seemed 
strange to me that a website devoted to news and commentary of this 
character would be interested in an article about government 
recommendations pertaining to salt intake. But their interest eventually 
became clear as some comments implied skepticism toward any claim that 
social determinants cause racial disparities. Instead, the comments 
suggested that fundamental differences between Whites and minorities 
explained Blacks’ poor health outcomes, and these outcomes were simply 
an indication of Blacks’ overall inferiority. 
A colleague of mine experienced a similar situation. Esteban González 
Burchard, a geneticist at the University of California, San Francisco, 
 
4.  Id. at 21 (emphasis added). 
5.  See Obasogie, supra note 1. See also Salt: Most Americans Should Consume Less Sodium, 
CDC, http://www.cdc.gov/salt (last updated Dec. 21, 2011). 
6.  The World Health Organization defines social determinants of health as: 
[T]he conditions in which people are born, grow, live, work and age, including the health 
system. These circumstances are shaped by the distribution of money, power and resources 
at global, national and local levels, which are themselves influenced by policy choices. The 
social determinants of health are mostly responsible for health inequities—the unfair and 
avoidable differences in health status seen within and between countries. 
Social determinants of health, WORLD HEALTH ORG., http://www.who.int/social_determinants/en (last 
visited Dec. 2, 2012). 
7.  Obasogie, supra note 1. 
8.  See WHITE-PRIDE, http://white-pride.org/2011/04/should-the-government-single-out-african-
americans-for-low-sodium-diets (last visited Apr. 20, 2011). This website has since been taken down 
and is no longer accessible. 
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researches asthma disparities in Latino communities; Puerto Ricans have 
the highest asthma prevalence, morbidity, and mortality, while Mexicans 
have the lowest.9 Much of Burchard’s research focuses on finding the 
genetic differences that may explain these disparities both within and 
among racial groups in order to develop treatments to improve minority 
health.10 Imagine Burchard’s surprise when he received an e-mail in 2007 
from former Louisiana politician—and former Grand Wizard for the Ku 
Klux Klan—David Duke,11 commending him for his research: 
 I do think your work and others who show real biological differences 
between races is important. You show that race is truly real, not a societal 
construct or some sort of conspiracy theory. As you know, there are about 
135 breeds (races) of dogs that are all part of the same species. They can 
all interbreed just as the human races can. Who can deny the differences 
in appearance, character, and physiology between dog breeds that can 
vary as much as the Maltese and the Great Dane? . . . Are we so blinded 
by egalitarian dogma that we can’t see the obvious differences in human 
races and their expressions in culture? As you are well aware, dog races, 
similarly to human races, have diseases that are specific to them. 
 The truth is, when it comes to human racial differences, we live in a 
world in which believing that “there is no such thing as human races” has 
become a religion, and those who recognize the realities of human races 
have become heretics who are called “racists.”12 
Another colleague, Dorothy Roberts, a professor of law and sociology 
at the University of Pennsylvania, experienced a similarly strange dynamic 
at an April 2006 conference on race-based medicine at the Massachusetts 
Institute of Technology.13 Roberts presented a paper on the lack of 
 
9.  Esteban González Burchard et al., Lower Bronchodilator Responsiveness in Puerto Rican 
than in Mexican Subjects with Asthma, 169 AM. J. RESPIRATORY & CRITICAL CARE MED. 386 (2004). 
10.  See e.g., Rajesh Kuman et al., Genetic Ancestry in Lung-Function Predictions, 363 NEW 
ENG. J. MED. 321 (2010); Rasika A. Mathias et al., A Genome-Wide Association Study on African-
Ancestry Populations for Asthma, 125 J. ALLERGY & CLINICAL IMMUNOLOGY 336 (2010); Haig 
Tcheurekdjian et al., ALOX5AP and LTA4H Polymorphisms Modify Augmentation of Bronchodilator 
Responsiveness by Leukotriene Modifiers in Latinos, 126 J. ALLERGY & CLINICAL IMMUNOLOGY 853 
(2010). 
11.  B. Drummond Ayres Jr., Political Briefing; Republicans Decide To Ignore David Duke, 
N.Y. TIMES, Apr. 18, 1999, http://www.nytimes.com/1999/04/18/us/political-briefing-republicans-
decide-to-ignore-david-duke.html; David Firestone, A Dealing with David Duke Haunts Louisiana 
Governor, N.Y. TIMES, June 22, 1999, http://www.nytimes.com/1999/06/22/us/a-dealing-with-david-
duke-haunts-louisiana-governor.htm. 
12.  David Duke, Race & Medicine: A Reply from David Duke, DAVID DUKE (Mar. 10, 2007, 
4:52 AM), http://www.davidduke.com/general/race-and-medicine-a-reply-from-david-duke-to-a-quote-
of-dr-esteban-burchard_1886.html. 
13.  Anne Pollock, Medicating Race: Heart Disease and Durable Preoccupations with Difference 
(May 1, 2007) (unpublished Ph.D. dissertation, Massachusetts Institute of Technology) (on file with 
author); DOROTHY ROBERTS, FATAL INVENTION: HOW SCIENCE, POLITICS, AND BIG BUSINESS RE-
CREATE RACE IN THE TWENTY-FIRST CENTURY 183–85 (2011). 
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consensus within the African American community on race-based 
medicine, or drugs that claim to be tailored to treat diseases in specific 
racial groups.14 Roberts described the diverse viewpoints within the Black 
community—from those who were skeptical of treating social categories of 
race as biologically-relevant labels to those who believe race-based 
medicine is an important step in resolving racial disparities in health. At the 
end of the talk, Juan Cofield, President of the NAACP’s New England 
Chapter, stood up and vigorously criticized Roberts by shouting, “There is 
consensus in the Black community that [BiDil, the first race-based 
medication for Blacks with heart failure,] is good for black people.”15 He 
then accused Roberts, who has had a celebrated career promoting racial 
justice and fighting health care inequalities, as irresponsibly jeopardizing 
Black people’s lives and suggested that their blood would be on her 
hands.16 Without blinking, Roberts calmly replied: “there isn’t a consensus 
[about BiDil] among black people in this room,”17 let alone among all 
members of the Black community, as Cofield suggested. 
These three situations reflect a growing crisis in lay and scholarly 
perspectives on race: a renewed legitimacy in what can be called 
“biological race,” or the idea that social categories of race reflect inherent 
biological differences that explain racial groups’ disparate social and health 
outcomes. Ever since the end of World War II—when the Holocaust 
exposed the horrors that ideas about biological race can produce—laws and 
social norms sympathetic to the idea that race is a social construction have 
fostered egalitarian sentiments. The social constructionist view explicitly 
rejects biological race, promoting instead the notion that different outcomes 
and abilities between races are linked to the privileges and burdens that 
society places on each group.18 This idea has been the intellectual 
foundation for advances in civil rights, human rights, and constitutional 
law.19 Modern notions of social and legal equality are premised on the 
concept that race reflects mere superficial differences and that variations in 
human abilities do not fall along racial lines. 
But new developments in genetic research are rehabilitating biological 
explanations for racial differences and disparities, creating unprecedented 
 
14.  ROBERTS, supra note 13, at 184. See also Pollock, supra note 13. 
15.  Pollock, supra note 13. See also ROBERTS, supra note 13, at 184 (“Juan Cofield stood up in 
the audience and emotionally objected. ‘There is consensus supporting BiDil,’ he shouted at me.”). 
16.  ROBERTS, supra note 13, at 184. 
17.  Pollock, supra note 13. 
18.  See infra Part II.G. 
19.  See infra Part II.G. 
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tensions for the regulatory state. For example, race-based medicines 
promise drugs that are tailored for optimal use in particular groups,20 
genetic ancestry tests claim to offer the ability to determine individuals’ 
racial and ethnic origins,21 and certain applications of DNA forensics 
leverage biological understandings of race to identify criminal suspects.22 
Compared to historical discussions on biological race, these new 
developments present a dramatic shift in tone. Past claims concerning 
biological race were used explicitly to subordinate racial minorities while 
current claims are often articulated as efforts to help reduce inequality by, 
for example, providing innovative mechanisms to resolve health disparities. 
What connects past and present, however, is a persistent belief in racial 
typologies, or that social categories of race reflect distinct biological 
groupings that are linked to essential traits and behaviors. It is through this 
shared thread of typological thinking that past ideas concerning racial 
hierarchy and meanings can be preserved in new technologies that may be 
facially benign or beneficent. 
This tonal shift is significant because the line between discriminatory 
and ostensibly beneficial uses of biological race is neither bright nor 
intuitive. For example, the aforementioned federal dietary guidelines treat 
race as a biological risk factor of the same consequence as advanced age or 
having diabetes for the laudable purpose of reducing health disparities in 
sodium-related diseases.23 On the other hand, those on White-Pride.org 
may embrace the very same biological understanding of racial disparities in 
health, but for a different reason: to assert Whites’ inherent superiority.24 
Similarly, Burchard’s research looking for genetic variations linked to 
asthma is motivated by an attempt to reduce racial disparities, while Duke’s 
support of this type of research most likely stems from a White-supremacist 
belief that minorities’ health problems are a function of their inferior 
physiology. And, although Roberts’s skepticism toward race-based 
medicine follows, in part, from a concern that the questionable science 
behind this approach might reinvent biological notions of race in a manner 
that ultimately disserves minority communities,25 the NAACP and other 
 
20.  See infra Part III.A. 
21.  See infra Part III.B. 
22.  See infra Part III.B. 
23.  DIETARY GUIDELINES FOR AMERICANS, supra note 2, at 55. 
24.  See the discussion of White-Pride.org, supra note 8. 
25.  ROBERTS, supra note 13, at 185 (“NitroMed did not make money from a drug that was 
developed to treat heart failure in black patients. It made money by converting a drug for heart failure 
into a drug for African Americans based on unsubstantiated claims about racial difference.”). 
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groups claiming to represent the Black community have endorsed race-
based medicine as a way to resolve racial disparities in health outcomes.26 
These tensions raise a critical legal and regulatory question: given the 
extraordinary amount of suffering linked to past government-enforced 
notions of biological race—from slavery to eugenics to Tuskegee—how are 
we to know when these new articulations further racial subordination or 
advance racial justice? This dichotomy draws attention to the remarkable 
stakes involved in devising sound regulatory approaches to vet new 
innovations premised upon biological understandings of racial difference 
and disparities. Overly permissive oversight mechanisms may allow 
problematic claims about race and genetics to engender discrimination and 
exacerbate racial inequality. On the other hand, excessively strict 
regulations may prevent potentially beneficial applications from helping 
those most in need. Because the intent behind the development of new 
technologies is not dispositive of the actual effect they will have on 
minorities or public conceptions of race, a broader assessment of these new 
technologies’ impact is needed to inform regulatory decision-making. 
This Article proposes race impact assessments as a new regulatory 
model for administrative agencies that creates a collaborative and 
deliberative space for multiple stakeholders to provide recommendations to 
regulators about how to balance the risks and benefits of new technologies 
that have the potential to give undue legitimacy to biological race. I draw 
upon prior impact assessment work in environmental law and other fields 
in which government agencies thoroughly assess new innovations’ broader 
impact before going forward. For example, just as an environmental impact 
assessment pursuant to the National Environmental Policy Act (“NEPA”) 
would look at the many ways a proposed federal highway might affect the 
surrounding environment and ecosystems, I similarly argue that proper 
regulation of new technologies that implicate race must also engage in a 
prospective assessment of their potential impact on racial minorities and 
public understandings of race. 
By proposing race impact assessments in this Article, I make a critical 
departure from mainstream legal and policy discussions on regulating the 
use of racial categories in science in at least two ways. First, the scholarly 
conversation and regulatory focus regarding developments pertaining to 
 
26.  Id. at 184 (“According to [the NAACP’s] view, the urgent crisis of African American heart 
disease must take precedence over political objections to the use of race as biomedical category. Indeed, 
these objections are seen as a form of racial discrimination or betrayal on grounds that they block black 
heart patients’ access to the medicines they need.”). 
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race and genetics have disproportionately centered on biomedicines (such 
as BiDil) without simultaneously examining how other biotechnologies are 
also giving new legitimacy to biological race.27 Genetic ancestry tests that 
use a direct-to-consumer model to give individuals information on their 
racial and ethnic backgrounds are reinforcing public understandings of race 
as a biologically-based, genetic entity that can be known by simply 
swabbing one’s cheek and mailing the results to a laboratory. Similarly, 
criminal investigators are using biotechnologies that implicate race in 
forensic investigations, which can influence public understandings of racial 
difference and has a distinct impact on minority communities. For example, 
law enforcement officials are using genetic analyses of unknown biological 
samples at crime scenes to develop visual depictions of possible suspects. 
This can include characteristics such as skin color, eye color, and facial 
features that ostensibly point directly to a suspect’s racial appearance.28 By 
arguing for race impact assessments that examine regulatory needs in all 
three areas—biomedicine, genetic ancestry tests, and DNA forensics—this 
proposal is able to assess these technologies’ synergistic effects across 
multiple fields and provide a more holistic regulatory mechanism that 
balances risks and benefits. 
Secondly, a significant and influential thread of the literature on 
regulating race-based biotechnologies draws upon constitutional law for a 
set of normative rules to govern if, how, and when new applications that 
use race as a biological marker of human difference should be made 
publically available.29 As a second departure, this Article’s proposed model 
does not rely on constitutional law to provide a set of normative rules to 
govern these technologies. Rather, I argue that administrative agencies—
the Food and Drug Administration (“FDA”) with regard to race-based 
medicine, the Federal Trade Commission (“FTC”) with regard to genetic 
 
27.  See, e.g., M. Gregg Bloche, Race-Based Therapeutics, 351 NEW ENG. J. MED. 2035 (2006); 
Richard S. Cooper et al., Race and Genomics, 348 NEW ENG. J. MED. 1166 (2003); Carlos Bustamante 
et al., Genomics for the World, 475 NATURE 163 (2011). 
28.  Gautum Naik, To Sketch a Thief: Genes Draw Likeness of Suspects, WALL ST. J., Mar. 27, 
2009, at A9. 
29.  See Jonathan Kahn, Genes, Race, and Population: Avoiding a Collision of Categories, 96 
AM. J. PUB. HEALTH 1965 (2006) [hereinafter Kahn, Genes, Race, and Population]; Erik Lillquist & 
Charles A. Sullivan, The Law and Genetics of Racial Profiling in Medicine, 39 HARV. C.R.-C.L. L. 
REV. 391 (2004); Osagie K. Obasogie, Beyond Best Practices: Strict Scrutiny as a Regulatory Model 
for Race-Specific Medicines, 36 J.L. MED. & ETHICS 491 (2008); Kimani Paul-Emile, The Regulation of 
Race in Science, 80 GEO. WASH. L. REV. 1115 (2012); Dorothy Roberts, Legal Constraints on the Use 
of Race in Biomedical Research: Toward a Social Justice Framework, 34 J.L. MED. & ETHICS 526 
(2006); David E. Winickoff & Osagie K. Obasogie, Race Specific Drugs: Regulatory Trends and Public 
Policy, 29 TRENDS IN PHARMACOLOGICAL SCI. 277 (2008). 
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ancestry tests, and the Federal Bureau of Investigation (“FBI”) with regard 
to DNA forensics—should be used as normative spaces to conduct race 
impact assessments that collaboratively investigate and discuss the 
potential impact these technologies might have for racial minorities and the 
idea of race. 
This Article proceeds in four additional parts. In Part II, I provide a 
brief history of biological race and law’s complicity in promoting racial 
typologies. By uncritically accepting scientific claims premised upon 
biological race, law has played a central role in promoting this pernicious 
way of thinking about human difference. This rich history situates this 
Article’s broader claim that state and federal governments’ past 
involvement in subordinating racial minorities through legal enforcements 
premised upon biological race obligate them to now implement oversight 
mechanisms such as race impact assessments to prevent such subordination 
from reoccurring. In Part III, I discuss three developments in human 
biotechnology that draw upon biological race and may have a particular 
impact on racial minorities: race-based medicine, genetic ancestry tests, 
and DNA forensics. In that section, I assess the scientific promise and 
limitations of these developments and highlight the concerns they raise 
with respect to renewing legitimacy in biological race in ways that may be 
harmful. In Part IV, I propose race impact assessments as a regulatory 
model for administrative agencies to balance these technologies’ potential 
risks and benefits. I then conclude with a discussion about why this 
proposed model is urgent for the future of racial justice. 
II. LAW, SCIENCE, AND BIOLOGICAL RACE: HISTORY AS 
CONTEXT 
This Section briefly examines the ascension of biological 
understandings of racial difference in the United States in the nineteenth 
and twentieth centuries, with a particular emphasis on the central role that 
law and science played in producing and embedding its significance. This 
is far from an exhaustive history; several books have been devoted to 
describing the development of racial thought in the West.30 Rather, this 
Section is designed to briefly sketch the trajectory of racial thought that has 
oriented itself around biology in order to understand the continuities and 
 
30.  See, e.g., GEORGE M. FREDRICKSON, THE BLACK IMAGE IN THE WHITE MIND: THE DEBATE 
ON AFRO-AMERICAN CHARACTER AND DESTINY, 1817–1914 (1971); WINTHROP D. JORDAN, WHITE 
OVER BLACK: AMERICAN ATTITUDES TOWARD THE NEGRO, 1550–1812 (1968) [hereinafter JORDAN, 
WHITE OVER BLACK]. 
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discontinuities between past and current articulations of biological race. 
The legal moments attended to in this Section—anti-miscegenation laws, 
immigration laws, and eugenics—serve as guideposts for understanding the 
unholy alliance between law and science in fostering the growth of 
biological race. The main point is that biological understandings of racial 
difference emerged at specific historical moments in response to particular 
social, economic, and political conditions filtered through scientific 
articulations of biological race. These understandings were promoted and 
maintained through the force of law to justify racial subordination. Law’s 
central role in absorbing, disseminating, and embedding past scientific 
justifications for biological race explains why it must now carefully attend 
to modern discussions of biological race as a way to atone for its past 
complicity in furthering racial injustice. 
A. SCIENTIFIC RACISM AND DARWINISM 
With regard to American race relations, religious and cultural 
differences have framed social categories of race as a reflection of inherent 
group differences since England’s earliest contact with people of color in 
Africa and the New World in the sixteenth and seventeenth centuries.31 
Distinctions between Christians and heathens on the one hand and civilized 
and savage peoples on the other gave content to what became increasingly 
racialized group distinctions that were thought of as innate differences 
driven by inborn abilities and disabilities.32 These perceived lines of 
difference served as a basis from which to determine human worth that, 
along with various social dynamics and economic needs, led to the 
development of racialized slavery in much of the New World and the 
American colonies.33 
Science has a long history of using quantitative methods to show that 
there are measureable physical distinctions between racial groups that 
explain differences and disparities in social and health outcomes. The 
 
31.  “[T]he English experience was markedly different from that of the Spanish and Portuguese 
who for centuries had been in close contact with North Africa and had actually been invaded and 
subjected by people both darker and more ‘highly civilized’ than themselves.” WINTHROP JORDAN, THE 
WHITE MAN’S BURDEN: HISTORICAL ORIGINS OF RACISM IN THE UNITED STATES 10 (1974) 
[hereinafter JORDAN, WHITE MAN’S BURDEN]. 
32.  Id. (“Englishmen and Christians everywhere were sufficiently acquainted with the concept 
of heathenism that they confronted its living representatives without puzzlement. Certainly the rather 
sudden discovery that the world was teeming with heathen people made for heightened vividness and 
urgency in the longstanding problem; but it was the fact this problem was already well formulated long 
before contact with Africa which proved important in shaping English reaction to the Negro’s defective 
religious condition.”). 
33.  See generally, JORDAN, WHITE OVER BLACK, supra note 30. 
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scientific method was used during the nineteenth century to both 
supplement and move away from purely religious or cultural explanations 
to frame racial differences and disparities as objectively knowable and 
measureable products of nature.34 Instead of merely referencing the Bible 
or cultural notions of savagery, science became an increasingly powerful 
way to objectively legitimize status-quo racial hierarchies.35 
Scholars have documented this practice across many disciplines for 
decades. Stephen Jay Gould’s The Mismeasure of Man details the ways in 
which biological notions of race were used in the nineteenth century to 
sustain racial hierarchies.36 Gould draws attention to how respected 
researchers like Samuel Morton, a Philadelphia physician who significantly 
influenced early American anthropology, measured the average head size 
of various races (the idea being that large heads signify greater cognitive 
ability) to establish a ranking system that provided seemingly objective 
data to explain and justify White racial dominance.37 Morton’s research 
was central to nineteenth-century American polygenesis—the then-popular 
theory that each race had separate origins—by legitimating the social order 
through measurable scientific claims.38 It is difficult to overstate his impact 
on public and scholarly understandings of race at the time. The New York 
Tribune wrote as an obituary that “probably no scientific man in America 
enjoyed a higher reputation among scholars throughout the world than Dr. 
Morton.”39 
Morton’s work is by far not the only example of how the scientific 
method came to play a prominent role in shaping scholarly and lay 
 
34.  See generally, LEE D. BAKER, FROM SAVAGE TO NEGRO: ANTHROPOLOGY AND THE 
CONSTRUCTION OF RACE, 1896-1954 (1998). 
35.  Id. 
36.  STEPHEN JAY GOULD, THE MISMEASURE OF MAN 83 (1996). 
37.  Morton amassed a dataset consisting of over six-hundred skulls, mostly from Native 
Americans, to show “that a ranking of races could be established objectively by physical characteristics 
of the brain, particularly by size.” Id. Gould’s argument that Morton fudged his measurements to fulfill 
white supremacist ideologies has recently been reexamined, with the authors arguing, “Morton did not 
manipulate data to support his preconceptions.” Jason E. Lewis et al., The Mismeasure of Science: 
Stephen Jay Gould versus Samuel George Morton on Skulls and Bias, 9 PLOS BIOLOGY 1 (2011). Upon 
reviewing this article by Lewis et al., the editors of Nature concluded that, taken at face value, their 
“critique leaves the majority of Gould’s work unscathed” and noted the article’s limitations in that the 
authors “couldn’t measure all of [Morton’s] skulls, [meaning that] they do not know whether the 
average cranial capacities that Morton reported represent his sample accurately.” The Nature editors 
also stated that although Lewis et al. accuse Gould of being driven by certain commitments in his 
reassessment of Morton’s data, “Lewis and his colleagues have their own motivations.” Editorial, 
Mismeasure for Mismeasure, 474 NATURE 419 (June 23, 2011). 
38.  GOULD, supra note 36, at 84. 
39.  Id. at 83. 
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understandings of race during this period.40 Science came to play an even 
stronger role in conceptualizing racial differences after the 1859 
publication of Charles Darwin’s On the Origins of Man. Darwin’s theory is 
quite simple: organisms’ traits are hereditary, adapting to environmental 
pressures and changing over time to confer survival advantages (evolution) 
through natural selection or sexual reproduction.41 Darwin was not the first 
to propose an evolutionary model for organisms’ development. His 
contribution was to theorize how evolution happens through natural 
selection; mating between the strongest and most attractive individuals 
provides survival advantages to subsequent generations and improves 
organisms’ overall strength and vitality.42 
Darwinism helped resolve a virulent debate among race commentators 
at the time: whether all humans had one single origin (monogenism) or 
whether each race had different and unrelated biological origins 
(polygenism).43 Darwinism presented the great compromise that 
superseded this theoretical impasse. Evolution by natural selection allowed 
monogenists to “win” part of the argument that man has one origin from 
which racial hierarchies with superior and inferior races evolved, while 
polygenists “won” in that the heritability of differences in ability appeared 
to be supported by the idea that great evolutionary distances separated the 
races.44 Put bluntly, the racist tendencies underlying each theory led to their 
consensus around evolution to the extent that “it provided an even better 
rationale for their shared racism.”45 
The close connection Darwin drew between human evolution and the 
ability to empirically document its different stages fueled a flame of 
measuring racial differences that had already been burning since the early 
nineteenth century. Scientists like Morton and his successors thought that if 
the races represented the stages of human evolution, measuring these 
differences would be absolutely crucial to giving these social observations 
 
40.  For a thorough examination of the different ways in which scientific measurements were 
used to identify racial difference, see THE NATURE OF DIFFERENCE: SCIENCES OF RACE IN THE UNITED 
STATES FROM JEFFERSON TO GENOMICS (Evelynn M. Hammonds & Rebecca M. Herzig eds., 2008). 
41. See generally CHARLES DARWIN, ON THE ORIGIN OF SPECIES (1859). 
42.  See Herbert Hovenkamp, Evolutionary Models in Jurisprudence, 64 TEX. L. REV. 645, 651 
(1985) (“The theory of natural selection in biology required only the production of numerous organisms 
and an environment so impoverished that it could accommodate only a few of them. The organisms 
thrown into this predicament were forced to compete, with the result that only a small number survived 
and reproduced.”). 
43.  GOULD, supra note 36, at 105. 
44.  Id. 
45.  Id. 
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scientific backing.46 Thus, as Thomas Gossett notes, the “nineteenth 
century [became] a period of exhaustive and, as it turned out, futile search 
for criteria to define and describe race differences.”47 
The ascension of measurement as defining proper scientific thought 
reified the notion that observing the status quo leads to racial truth 
concerning groups’ inherent abilities, which intensified the scrutiny given 
to racial bodies that predicated post-Civil War race relations. Racial bodies 
and their performances became subject to exacting visual attention as part 
of an effort to explain racial minorities’ natural state as degraded and 
inferior.48 In post-Civil War America, this type of policing became a new 
type of social control. The Civil War and ensuing constitutional 
Amendments may have formally liberated Blacks, but science became the 
new basis for continuing their social and legal degradation. Blacks’ limited 
progress was explained as so natural, normal, and predictable by scientific 
observations that even laypeople could appreciate it by simply looking out 
into the world. 
Indeed, legal historian Ariela Gross notes that after the Civil War, “the 
color line replaced the boundary between free and slave, race replaced 
slave status, and a regime of whiteness replaced the regime of slavery as 
the weapon of oppression.”49 Gross argues that science played a key role in 
these transformations in that “it was [during] the post-Civil War period that 
racial science triumphed and became the single argument for explaining 
‘race.’”50 This is a subtle but important point that deserves attention. 
Although the Civil War and Reconstruction Amendments provided 
powerful mechanisms to make Blacks full citizens, there were equally 
powerful opposing forces determined to maintain racial subordination. The 
increasingly sophisticated notion of race-as-biology played this key role: 
providing a rational and objectively verifiable measurement system that 
 
46.  THOMAS GOSSETT, RACE: THE HISTORY OF AN IDEA IN AMERICA 68–69 (1963). 
47.  Id. at 69. Gould corroborates this sentiment by noting that the second half of the nineteenth 
century was distinguished by: 
the allure of numbers, the faith that rigorous measurement could guarantee irrefutable 
precision, and might mark the transition between subjective speculation and a true science as 
worthy as Newtonian physics. Evolution and quantification formed an unholy 
alliance. . . . By the end of Darwin’s century, standardized procedures and a developing 
body of statistical knowledge had generated a deluge of more trustworthy numerical data. 
GOULD, supra note 36, at 106. 
48.  See generally, Ariela Gross, Litigating Whiteness: Trials of Racial Determination in the 
Nineteenth-Century South, 108 YALE L. J. 109 (1998). 
49.  Id. at 177. 
50.  Id. 
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demonstrated racial minorities’ inferiority as natural, inherent, and 
heritable. Within this warped Darwinian framework, this not only justified 
the status quo, but gave moral impetus to the belief that to try to change 
these status relationships would be contrary to evolutionary progress and, 
thus, society itself. 
B. SOCIAL DARWINISM AND EUGENICS 
The social sciences became particularly useful in justifying 
inequalities “in terms of a natural hierarchy of class and race caused by a 
struggle for existence wherein the fittest individuals or races advanced 
while the inferior became eclipsed.”51 These popular terms—“the struggle 
for existence” or more often “the survival of the fittest”—are often 
attributed to Charles Darwin, but actually belong to Herbert Spencer.52 
Spencer, an Englishman, had a profound impact on American social 
sciences. Although Darwin often balked at directly applying his 
evolutionary thought to social relations, Spencer developed his own quasi-
evolutionary theories before Darwinism hit the scene that treated social 
organisms the same way Darwin approached biological ones.53 Thus, 
Spencer advocated what came to be known as Social Darwinism: “the idea 
of natural selection was translated to a struggle between individual 
members of society[;] . . . nature’s indispensable method for producing 
superior men, superior nations, and superior races.”54 In the context of both 
Darwin’s rock-star status in the United States and the postwar need for 
rational explanations of human difference, Spencer’s “biological analogy” 
was, to put it mildly, the right theory at the right time. The parallels 
Spencer made between the natural and social sciences were simply too 
elegant and seductive for Americans to resist.55 
Race became a key framing for Social Darwinism. For example, 
Spencer analogized the evolutionary gap between savage and civilized 
minds as being akin to the gulf in cognitive abilities between juveniles and 
 
51.  BAKER, supra note 34, at 27. 
52.  JOSEPH GRAVES, THE EMPEROR’S NEW CLOTHES: BIOLOGICAL THEORIES OF RACE AT THE 
MILLENNIUM 75 (2003). 
53.  HERBERT SPENCER, SOCIAL STATICS: OR, THE CONDITIONS ESSENTIAL TO HUMAN 
HAPPINESS SPECIFIED, AND THE FIRST OF THEM DEVELOPED 426 (1851) (“Regarding society as an 
organism, . . . it is impossible artificially to use up social vitality for the more active performance of one 
function without diminishing the activity with which other functions are performed. So long as society 
is let alone, its various organs will go on developing in due subordination to each other.”). 
54.  GOSSETT, supra note 46, at 145. 
55.  See id. at 144–75. 
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adults.56 Here, as throughout this period, social scientific measurements 
merged with Social Darwinist theory to reveal the evolutionary and 
biological hierarchies embedded in these race discourses through quantified 
comparisons of geographically separated and visually distinguishable 
groups.57 
With the intellectual and “scientific” basis for conceptualizing and 
measuring racial hierarchy establishing itself throughout the nineteenth 
century, the question at the turn of the twentieth century became quite 
pragmatic: What should be done about it? This context gave rise to the 
eugenics movement, which was an international effort to use science and 
medicine to justify limiting the reproduction—and existence—of 
individuals deemed to be of an inferior racial stock while promoting the 
reproduction of those thought to be racially superior.58 Also known as 
“racial hygiene,” eugenics came to dominate social, political, and legal 
thought in the early twentieth century across America and Western Europe, 
leading law and public policy to become complicit in the devastating and 
brutal treatment of the most vulnerable populations.59 The incorporation of 
scientific understandings of biological race into American law and public 
policy during this period can be seen in at least three ways: immigration 
restrictions, forced sterilizations, and anti-miscegenation laws. 
1. Immigration Restrictions 
Immigration was an important aspect of late-nineteenth and early-
twentieth-century eugenics ideology because population control was seen 
as central to managing the United States’ racial composition.60 Chinese 
laborers were drawn to the West Coast after the Civil War to assist with 
railroad construction, mining, and other manual labor.61 At first, Americans 
welcomed this cheap and plentiful labor, but soon disparaged it as 
economic conditions worsened.62 Anti-Chinese sentiments spurred by 
 
56.  Herbert Spencer, The Comparative Psychology of Man, J. ANTHROPOLOGICAL INST. OF GR. 
BR. & IR., 301, 303–04 (1876). 
57.  See GOSSETT, supra note 46, as 144–75. 
58.  Garland E. Allen, Eugenics and Modern Biology: Critiques of Eugenics, 1910–1945, 75 
ANNALS HUM. GENETICS 314 (2011). 
59.  Id. 
60.  Ian F. Haney López writes, “The racial composition of the U.S. citizenry reflects in part the 
accident of world migration patterns. More than this, however, it reflects the conscious design of U.S. 
immigration and naturalization laws.” IAN F. HANEY LÓPEZ, WHITE BY LAW: THE LEGAL 
CONSTRUCTION OF RACE 37 (1996). 
61.  Kitty Calavita, The Paradoxes of Race, Class, Identity, and “Passing”: Enforcing the 
Chinese Exclusion Acts, 1882–1910, 25 LAW & SOC. INQUIRY 1, 4 (2000). 
62.  Id. 
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organized labor and general social anxieties toward racial otherness led to 
an understanding of Chinese individuals as a separate and biologically 
different group.63 Much of this anxiety stemmed from the disproportionate 
number of Chinese men immigrating: the 1890 Census showed 102,620 
Chinese men versus 3868 Chinese women present in the United States.64 
This imbalance resulted in a heightened threat of sexual competition 
and mixed-race offspring thought to be biologically inferior, leading to 
various state and local restrictions on Chinese immigration that eventually 
percolated to the federal level.65 For example, an 1877 Congressional 
report by the Joint Special Committee to Investigate Chinese Immigration 
noted that, “there is not sufficient brain capacity in the Chinese race to 
furnish motive power for self-government. Upon the point of morals, there 
is no Aryan or European race which is not far superior to the 
Chinese . . . .”66 This was followed by a series of Chinese Exclusion Acts 
beginning in 1882 that limited Chinese laborers’ ability to enter the United 
States. The Supreme Court upheld the constitutionality of these acts in 
1889 in Chae Chan Ping v. United States: 
The differences of race added greatly to the difficulties of the 
situation. . . . It seemed impossible for them to assimilate with our people 
or to make any change in their habits or modes of living. As they grew in 
numbers each year the people of the coast saw, or believed they saw, in 
the facility of immigration, and in the crowded millions of China, where 
population presses upon the means of subsistence, great danger that at no 
distant day that portion of our country would be overrun by them unless 
prompt action was taken to restrict their immigration.67 
This sentiment toward Chinese individuals as an unassimilable and 
biologically distinct racial group persisted in further legislative acts and 
judicial decisions throughout this period. Justice Harlan’s 1896 dissent in 
Plessy v. Ferguson, where he advocated colorblindness in questioning the 
constitutionality of separate but equal railroad accommodations for Whites 
and Blacks, noted that “there is a race so different from our own that we do 
not permit those belonging to it to become citizens of the United 
States. . . . I allude to the Chinese race.”68 This notion of intractable 
difference as a predicate for racial exclusion via immigration policies was 
 
63.  See id. 
64.  Id. 
65.  Id. 
66.  Id. (quoting U.S. CONG. JOINT SPECIAL COMM. TO INVESTIGATE CHINESE IMMIGR., S. REP. 
NO. 44-689 (1877)). 
67.  Chae Chan Ping v. United States, 130 U.S. 581, 595 (1889). 
68.  Plessy v. Ferguson, 163 U.S. 537, 561 (1896) (Harlan, J., dissenting). 
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also captured through various aspects of popular culture. For example, in 
this advertisement from circa 1900, the message that “they must go” 
conflates the product’s pest control abilities with broader political 
sentiments concerning biological difference and Chinese exclusion.69 
Chinese people are depicted as more rodent-like than human. 
 
Figure 1: Advertisement70 
However Chinese people were not the only group targeted for 
immigration restrictions. At the same time, White racial purity was 
idealized in particular ways. It “favored the ‘Nordics’ of northern and 
western Europe over the ‘undesirable races’ of eastern and southern 
Europe.”71 The late nineteenth and early twentieth centuries witnessed a 
large influx of immigrants from eastern and southern Europe, creating 
hysteria similar to that on the West Coast pertaining to Chinese 
immigration.72 Many feared that the idealized Nordic bloodstream would 
be diluted and overrun by White Europeans of a lesser stock.73 Yale 
 
69.  David Segal, Uncle Ben, CEO?, SLATE, Apr. 20, 2007, 
http://www.slate.com/articles/arts/culturebox/2007/04/uncle_ben_ceo.html (follow hyperlink to slide 
show essay). 
70.  Id. 
71.  Mae M. Ngai, The Architecture of Race in American Immigration Law: A Reexamination of 
the Immigration Act of 1924, 86 J. AM. HIST. 67, 69 (1999). 
72.  DANIEL J. KEVLES, IN THE NAME OF EUGENICS: GENETICS AND THE USES OF HUMAN 
HEREDITY 96 (1985). 
73.  Id. at 96–97. 
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historian Daniel Kevles notes that, with regard to immigration debates in 
Washington in the 1920s, “[o]n both sides of Capitol Hill biological and 
racial arguments figured prominently in the floor debate. . . . Congressman 
Robert Allen, Democrat of West Virginia, declared: ‘The primary reason 
for the restriction of the alien stream . . . is the necessity for purifying and 
keeping pure the blood of America.’”74 These discussions led to the 
passage of the Immigration Act of 1924,75 which restricted immigration 
from Eastern Europe.76 It was signed by President Calvin Coolidge, who 
previously as vice president said that “America must be kept American. 
Biological laws show . . . that Nordics deteriorate when mixed with other 
races.”77 
2. Forced Sterilizations 
While most people associate the eugenics movement with the horrors 
of Nazi Germany, many fail to acknowledge that the world’s first eugenics 
sterilization law was implemented in Indiana in 1907 and that the Nazis 
looked to American eugenicists for guidance on how to pursue racial 
hygiene.78 In fact, forced sterilization laws were extremely popular in the 
United States. Between 1907 and 1963, more than 60,000 Americans were 
sterilized against their will pursuant to state laws.79 The number of state 
laws and compulsory sterilizations accelerated after the 1927 Supreme 
Court decision Buck v. Bell,80 where the Court upheld the forced 
sterilization of an ostensibly feebleminded Carrie Buck because, as Justice 
Oliver Wendell Holmes famously declared, “[i]t is better for all the world, 
if instead of waiting to execute degenerate offspring for crime, or to let 
them starve for their imbecility, society can prevent those who are 
manifestly unfit from continuing their kind. . . . Three generations of 
imbeciles are enough.”81 
Although compulsory sterilizations affected many groups, from the 
disabled to those who were simply poor and without opportunities for self-
betterment, biological notions of race, inferiority, and human difference 
 
74.  Id. at 97. 
75.  Immigration Act of 1924, 43 Stat. 153 (repealed 1952). 
76.  KEVLES, supra note 72, at 97. 
77.  Id. 
78.  EDWIN BLACK, WAR AGAINST THE WEAK: EUGENICS AND AMERICA’S CAMPAIGN TO 
CREATE A MASTER RACE 280 (2003). 
79.  Hoangmai H. Pham & Barron H. Lerner, In the Patient’s Best Interest? Revisiting Sexual 
Autonomy and Sterilization of the Developmentally Disabled, 175 W. J. MED. 280, 280–81 (2001). 
80.  Id. at 280. 
81.  Buck v. Bell, 274 U.S. 200, 207 (1927). 
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drove these practices’ ideological implementation.82 The “defects” that 
these polices sought to eliminate were thought to be heritable through 
reproduction. But even within the broad range of affected groups, racial 
minorities disproportionately bore the brunt of these policies. The social 
and physical defects sought to be eliminated—such as criminality, 
feeblemindedness, and loose sexual morals—were thought to be 
disproportionately present among people of color. For example, between 
1937 and 1968, federal funds were used to sterilize over 35 percent of 
women in Puerto Rico who were in their reproductive years.83 Native 
American women were similarly targeted for eugenic sterilization as early 
as the 1930s.84 Between the early 1970s and early 1980s, the Indian Health 
Services forcibly sterilized 42 percent of all Native American women of 
childbearing age.85 Black people have also been disproportionally targeted. 
For example, Harriet Washington notes, “When the North Carolina 
Eugenic Commission sterilized 8,000 mentally retarded persons throughout 
the 1930s, 5,000 were black.”86 Forced sterilization became so routine in 
some Southern Black communities that they were commonly referred to as 
“Mississippi [a]ppendectom[ies].”87 Therefore, the very biological 
characteristics that the State sought to reduce were themselves racialized. 
 
82.  See id. 
83.  Katharine Karse, The Politics of Women’s Health: Sterilization Abuse, WOMEN’S HEALTH 
ACTIVIST (Nat’l Women’s Health Network), Jan.–Feb. 1996, available at 
http://www.ourbodiesourselves.org/book/companion.asp?id=31&compID=55. Angela Hooton puts 
Latina women’s experience with forced sterilization in a broader context: 
Thousands of Latinas, specifically Puerto Rican, Dominican and Mexican-American 
women, suffered from forced or coercive sterilization from the 1950s until the late 1970s. 
Many of these women were sterilized in public hospitals immediately following childbirth. 
Evidence indicates that some women were not aware that the procedure was happening or 
that it would be permanent. For example, one of the most egregious sterilization practices 
occurred at the Los Angeles County Medical Hospital, where Mexican-origin women were 
sterilized during or immediately following childbirth, without adequate information or 
necessary translation. 
Angela Hooton, A Broader Vision of the Reproductive Rights Movement: Fusing Mainstream and 
Latina Feminism, 13 AM. U. J. GENDER SOC. POL’Y & L. 59, 70–71 (2005) (internal citations omitted). 
84.  Lindsay Glauner, Comment, The Need for Accountability and Reparation: 1830–1976 the 
Unites States Government’s Role in the Promotion, Implementation, and Execution of the Crime of 
Genocide Against Native Americans, 51 DEPAUL L. REV. 911, 939 (2002). 
85.  Id. See also Jane Lawrence, The Indian Health Service and the Sterilization of Native 
American Women, 24 AM. INDIAN Q. 400 (2000). 
86.  HARRIET A. WASHINGTON, MEDICAL APARTHEID: THE DARK HISTORY OF MEDICAL 
EXPERIMENTATION ON BLACK AMERICANS FROM COLONIAL TIMES TO THE PRESENT 203 (2006). 
87.  Id. at 204. 
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3. Anti-Miscegenation Laws 
Attempts to legally restrict interracial marriage, sex, and reproduction 
date back to the seventeenth century, with the first anti-miscegenation 
statute legislated in Maryland in 1661. Virginia followed suit in 1662.88 
While opposition to interracial sex and marriage had some theological 
influences,89 notions of biological race and the desire to prevent the 
degradation of White racial purity were present from the very beginning. 
For example, a 1691 Virginia statute banished Whites who married 
interracially with Blacks, American Indians, or those of a mixed race “for 
[the] prevention of that abominable mixture and spurious issue.”90 Keith E. 
Sealing notes that up until 1967, when anti-miscegenation laws were held 
unconstitutional in Loving v. Virginia,91 they were justified by themes 
resonating back to the colonial times, regardless of their basis in science or 
religion: 
First, there is a natural hierarchy of all beings in the universe. Second, 
humans are part of this chain. Third, “race” is a valid concept. Fourth, the 
races can be ranked hierarchally: Whites are the superior race, 
Asians/Indians are second, and Blacks last. Fifth, this ranking of the races 
is immutable. Sixth, miscegenation, the crossing of the races, produces 
crosses that are inferior to either parent. Seventh, mixed races have lower 
fertility. Eighth, mixing of the races brings the better down to the level of 
the lower, rather than improving the lower.92 
The eugenics movement brought renewed interest in government 
regulation of reproduction through marriage; “by 1914, some thirty states 
had enacted new marriage laws or amended old ones.”93 This coincided 
with the fact that “[e]very state whose [B]lack population reached or 
exceeded 5 percent of the total eventually drafted and enacted anti-
miscegenation laws.”94 Eugenicists often played a significant role in 
passing anti-miscegenation laws during this period in that “they were part 
 
88.  RACHEL F. MORAN, INTERRACIAL INTIMACY: THE REGULATION OF RACE AND ROMANCE 19 
(2001). 
89.  The scriptural basis for Blacks’ state of inferiority and servitude stems from the story of 
Noah cursing Ham for seeing him naked while drunk. See Genesis 9:20–27. 
90.  A. Leon Higginbotham, Jr. & Barbara K. Kopytoff, Racial Purity and Interracial Sex in the 
Law of Colonial and Antebellum Virginia, 77 GEO. L.J. 1967, 1995 (1989) (quoting Act SVII entitled 
“An Act for Suppressing Outlying Slaves” from THE STATUTES AT LARGE; BEING A COLLECTION OF 
ALL THE LAWS OF VIRGINIA, VOL. III, 86–87 (1823)). 
91.  Loving v. Virginia, 388 U.S. 1 (1967). 
92.  Keith E. Sealing, Blood Will Tell: Scientific Racism and the Legal Prohibitions Against 
Miscegenation, 5 MICH. J. RACE & L. 559, 560–65 (2000). 
93.  KEVLES, supra note 72, at 99. 
94.  RANDALL KENNEDY, INTERRACIAL INTIMACIES: SEX, MARRIAGE, IDENTITY, AND ADOPTION 
219 (2003). 
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of a coalition that put the laws on the books, and they provided prior (or, at 
times, post hoc) biological rationalizations for what other interest groups 
wanted.”95 
C. CONCEPTIONS OF RACE AFTER WORLD WAR II 
It is largely believed that biological understandings of race completely 
disappeared after the end of World War II in 1945, as the consequences of 
eugenic policies’ most horrific implementation—the Holocaust—were 
fully revealed to the world. However, certain eugenic practices, such as 
state-level forced sterilization, did not end until the 1970s.96 The 1950 
United Nations Educational, Scientific and Cultural Organization 
(“UNESCO”) Statement on Race is often referenced as the proverbial 
obituary for biological race. In this document, a group of esteemed 
scientists declared: 
The biological fact of race and the myth of “race” should be 
distinguished. For all practical purposes “race” is not so much a biological 
phenomenon as a social myth. The myth of “race” has created an 
enormous amount of human and social damage. . . . It still prevents the 
normal development of millions of human beings and deprives 
civilization of the effective co-operation of productive minds. The 
biological differences between ethnic groups should be disregarded from 
the standpoint of social acceptance and social action.97 
Not all scientists agreed with this bold statement about the biological 
irrelevance of race,98 and that pushback was incorporated into subsequent 
UNESCO statements.99 Nevertheless, the scientific community’s overall 
sentiment at the time was that the old, crude biological understanding of 
race was no longer accepted. Or, as the New York Times proclaimed when 
 
95.  KEVLES, supra note 72, at 100. 
96.  For example, North Carolina continued its forced sterilization program until the 1974. NC 
Justice for Sterilization Victims Foundation, N.C. DEP’T ADMIN., 
http://www.sterilizationvictims.nc.gov (last visited Dec. 2, 2012). 
97.  Statement by Experts on Race Problems, UNESCO Doc. SS/1, at 3–4 (July 20, 1950), 
available at http://unesdoc.unesco.org/images/0012/001269/126969eb.pdf. 
98.  JENNY REARDON, RACE TO THE FINISH: IDENTITY AND GOVERNANCE IN AN AGE OF 
GENOMICS 29 (2005). 
99.  Id. at 30–31. Reardon writes: 
Following its publication on 18 July 1950, the First UNESCO Statement on Race received 
heavy criticism, especially from physical anthropologists and geneticists. For many of these 
scientists, the critical problem with the First UNESCO Statement was that while it advocated 
giving scientists a greater role in defining race in society, ironically it limited their ability to 
define race in their own research. 
Id. at 29 (internal citations omitted). 
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reporting on the UNESCO statement’s release in 1950: “No Scientific 
Basis for Race Bias Found by World Panel of Experts.”100 
In addition to marking the end of the widespread recognition of 
biological race, the UNESCO statement is also seen as the moment where 
the social-constructionist view on race became widely accepted. This 
perspective views race as a social, political, and legal fabrication rather 
than a fixed biological fact. While scholars such as Franz Boas argued 
against biological race decades before the end of World War II,101 many 
people point to the UNESCO Statement and its surrounding discourse as 
the intellectual tipping point whereby social constructionism became the 
dominant perspective. For example, in his history of scientific racism, 
Elazar Barkan, a professor of international and public affairs at Columbia 
University, writes that with the 1950s UNESCO Statement, “[t]he reversal 
in the scientific credo on [biological] race since the early 1920s had been 
completed.”102 
During this postwar period, most scientists stopped talking about races 
in favor of populations. Population genetics is widely interpreted as 
representing a crucial scientific turn away from examining qualitative or 
typological categories of difference and toward measuring quantitative 
differences in the distribution and frequency of genetic variations among 
and between certain groups.103 Rather than focusing on categorizing people 
by phenotype, population genetics is thought to have put scientific racism 
in the past by focusing its attention on the genotypes of various 
populations.104 But, a number of scholars question this interpretation. 
Instead of marking a clear move in an anti-racist direction,105 they argue 
 
100.  No Scientific Basis for Race Bias Found by World Panel of Experts, N.Y. TIMES, July 18, 
1950, at 1. 
101.  See REARDON, supra note 98, at 90. 
102.  ELAZAR BARKAN, THE RETREAT OF SCIENTIFIC RACISM: CHANGING CONCEPTS OF RACE IN 
BRITAIN AND THE UNITED STATES BETWEEN THE WORLD WARS 341 (1992). 
103.  REARDON, supra note 98, at 32–33. “[H]istorians of race and science draw upon five 
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approach: race/population; race/culture; classificatory/empirical; history/natural selection; 
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104.  Id. 
105.  In describing the anti-racism that is often presumed to have been ushered in with a 
population focus, Lisa Gannett, Associate Professor of Philosophy at Saint Mary’s University, writes: 
“Population thinkers” are considered to be averse to the imposition of artificial and arbitrary 
“typologies” on heterogeneous biological nature. For this reason, they are supposed to be 
open to recognizing the . . . empirical evidence that genetic variability is distributed 
statistically across the species, and thus the invalidation of classification schemes that 
attempt to categorize each and every human being as belonging to a discrete racial kind or 
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that the shift in the life sciences from “race” to “population” is ambiguous 
and that typological approaches to human difference continue to influence 
population approaches to race and genetics.106 As University of California, 
Santa Cruz, sociologist Jenny Reardon concludes in her historical account 
of this period and its reverberating effects on modern race and genetics 
research agendas: 
[N]o consensus about the role of race in studying human origins and 
diversity emerged following World War II. Physical anthropologists and 
geneticists did not all agree—contrary to prevalent historical opinion—
that race had no biological meaning, and should be replaced by a study of 
populations. Not even did all agree that typologies had no use in science. 
Rather, most sought to redefine scientific ideas and practices for studying 
race (including typologies) in the wake of what many perceived as the 
abuse of these ideas and practices by eugenicists, segregationists, and the 
Nazis.107 
This lack of actual agreement in the life sciences concerning the 
biological significance of race (in the face of assumed consensus in 
virtually all other fields) sets the stage for understanding its continuing 
significance in the twenty-first century. The point is not to frame the post-
World War II period as an overly broad dichotomy between public 
articulations that race is biologically insignificant and ongoing research 
specifically premised on the idea that race reflects inherent and heritable 
differences. Rather, it is simply to note that the standard narrative that 
biological race disappeared after World War II is at best incomplete and, at 
worst, deceptive in that it can obscure connections between past and 
present racial typologies in science. In particular, this dichotomy highlights 
the perfidious relationship between race and science in contemporary 
research and why continued discussion and oversight of this issue is 
needed. With this understanding of biological race and its contested 
intellectual history, we can now examine new developments in race and 
genetics to think through their points of convergence and divergence with 
past discussions on biological race. 
 
two individuals from different groups can be genetically more similar than two individuals 
from the same group because of the extent to which allele frequency distributions in 
populations are overlapping. 
Lisa Gannett, Racism and Human Genome Diversity Research: The Ethical Limits of “Population 
Thinking”, 68 PHIL. SCI. S479, S489 (2001). 
106.  Id. at S488–89 (internal citation omitted). 
107.  REARDON, supra note 98, at 42. 
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III. BIOLOGICAL RACE IN THE TWENTY-FIRST CENTURY 
Developments in human biotechnology across the past decade have 
renewed claims that social categories of race reflect inherent biological 
differences that explain disparities in social and health outcomes. This 
Section assesses three of these new technologies: race-based medicine, 
genetic ancestry tests, and certain aspects of DNA forensics. While each of 
these applications developed separately, they are united by a shared effort 
that reinvigorates the racial typologies thought to be dismissed in the 
1950s: that racial differences are real, meaningful, and measureable at the 
molecular level. This Section examines the claims made by each 
technology, their supporting science, and the concerns raised in order to 
better understand the potential risks and benefits associated with 
rearticulating biological race in these new terms. 
A. RACE-BASED MEDICINE 
1. Claims Made 
Race-based medicine hit the scene in 2005, when BiDil became the 
first drug to receive FDA approval to treat a specific racial group: African 
Americans suffering from congestive heart failure.108 Congestive heart 
failure affects the heart’s ability to efficiently pump blood throughout the 
body and is caused largely by deteriorating heart muscle.109 Although 
millions of Americans suffer from this condition,110 BiDil’s FDA approval 
was largely driven by data demonstrating that Blacks are twice as likely to 
suffer from heart failure as Whites.111 NitroMed,112 the company that 
originally developed BiDil, used this claim throughout the regulatory 
process to imply that biological mechanisms led Blacks to have a different 
experience with the disease and to justify the unprecedented regulatory 
move to label this new drug for a specific race.113 
 
108.  Jonathan Kahn, Race in a Bottle, SCI. AM., Aug. 2007, at 40 [hereinafter Kahn, Race in a 
Bottle]. 
109.  Id. 
110.  “[A]n estimated 5,700,000 Americans ≥20 years of age have [heart failure].” Véronique L. 
Roger et al., Heart Disease and Stroke Statistics—2012 Update: A Report Filed From the American 
Heart Association, CIRCULATION, Jan. 3/10, 2012, at e2, e102, available at 
http://circ.ahajournals.org/content/125/1/e2. 
111.  Jonathan Kahn, Getting the Numbers Right: Statistical Mischief and Racial Profiling in 
Heart Failure Research, 46 PERSP. BIOL. & MED. 472, 474 (2003) [hereinafter Kahn, Getting the 
Numbers Right]. 
112.  Deerfield Capital acquired NitroMed, a Massachusetts-based biotechnology firm, in 2009 
for approximately $36 million. Deerfield Wins NitroMed with Sweetened Offer, DEALBOOK, Feb. 2, 
2009, http://dealbook.nytimes.com/2009/02/02/deerfield-wins-nitromed-with-sweetened-offer. 
113.  Kahn, Race in a Bottle, supra note 108, at 44. 
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The story behind BiDil’s clinical development is important for 
understanding how and when this groundbreaking claim of race specificity 
became relevant. BiDil combines two standard therapies to treat heart 
failure—hydralazine and isosorbide dinitrate—into one pill.114 These 
generics have been used for decades across all races to treat heart failure.115 
BiDil began with two clinical trials in the 1980s: V-HeFT I and V-HeFT 
II.116 The V-HeFT I trial lasted from 1980 to 1985 and found that patients 
who received the hydralazine/isosorbide dinitrate (“H/I”) combination 
therapy had lower mortality outcomes.117 V-HeFT II, lasting from 1986 to 
1989, compared this same combination therapy to an ACE inhibitor118 
called enalapril. The trial showed that H/I was more effective.119 However, 
it is important to keep in mind that “[t]he V-HeFT investigators did not 
build the trials around race or ethnicity. They enrolled both Black and 
White patients and in the published reports of the trials’ successes, they did 
not break down the data by race. Rather, they presented H/I (the BiDil 
drugs) as generally efficacious in the population at large, without regard to 
race.”120 
In 1989 Dr. Jay Cohn, who led the two V-HeFT studies, received a 
patent on the method of administering the H/I combination therapy to treat 
heart failure, without reference to race.121 Cohn then licensed the drug to 
Medco Research, a biotechnology company that then manufactured the 
components into one pill that became BiDil.122 The FDA rejected BiDil’s 
approval in 1997, noting problems with the statistical design of the V-
 
114.  Id. at 40. 
115.  Id. 
116.  Id. at 41. 
117.  Jay N. Cohn et al., Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart 
Failure, 314 NEW ENG. J. MED. 1547, 1551 (1986). 
118.  Commonly called “ACE inhibitors,” angiotensin-converting enzyme inhibitors “help relax 
blood vessels” and are used to “treat a variety of conditions,” including heart failure. Angiotensin-
Converting Enzyme (ACE) Inhibitors, MAYO CLINIC, http://www.mayoclinic.com/health/ace-
inhibitors/HI00060 (last updated Dec. 16, 2010). 
119.  Jay Cohn et al., A Comparison of Enalapril with Hydralazine-Isosorbide Dinitrate in the 
Treatment of Chronic Congestive Heart Failure, 325 NEW ENG. J. MED. 303, 307 (1991). 
120.  Jonathan Kahn, From Disparity to Difference: How Race-Specific Medicines May 
Undermine Policies to Address Inequalities in Health Care, 15 S. CAL. INTERDISC. L.J. 105, 109 (2005) 
[hereinafter Kahn, From Disparity to Difference]. 
121.  See Kahn, Race in a Bottle, supra note 108, at 42. 
122.  Id. For a more detailed description of these events, see Jonathan Kahn, How a Drug 
Becomes “Ethnic”: Law, Commerce, and the Production of Racial Categories in Medicine, 4 YALE J. 
HEALTH POL’Y L. ETHICS 1 (2004). 
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HeFT trials.123 Cohn then went back to the V-HeFT data and found that 
African Americans gained a particular benefit from the combination 
therapy.124 He then filed for and was granted a patent identical to the first 
one, except that the use was now for African Americans suffering from 
heart failure, which had the financial and commercial benefit of extending 
his patent rights an additional thirteen years.125 Cohn licensed BiDil to 
NitroMed, who conducted a clinical trial—the African American Heart 
Failure Trial (“A-HeFT”)—to test BiDil’s race-specific benefit.126 The A-
HeFT trial only included participants that self-identified as African 
American.127 The trial yielded data demonstrating a 43 percent reduction in 
mortality, leading the FDA to approve a race-specific indication for use by 
Blacks with heart failure.128 
BiDil’s clinical trial design, results, and subsequent FDA approval 
supports at least three different claims about the biological significance of 
race in relation to racial disparities in disease progression and health 
outcomes. Because BiDil is the first drug to be (1) patented as race-
specific, (2) approved by the FDA as race-specific, and (3) marketed as 
race-specific, it has come to reflect the legal, regulatory, and economic 
sanctioning of race as a biologically significant category of human 
difference that meaningfully affects human health. Through this framing, 
social categories of race appear to be significant markers for otherwise 
hard-to-detect biological differences in human populations. Neither Cohn 
nor any of his collaborators have been able to identify the biological 
markers responsible for Blacks’ receptiveness to BiDil.129 But this lack of 
specificity seemed to be of little consequence for regulators, who embraced 
the typological sensibilities embedded in biological understandings of race. 
They assumed that self-identified race mirrored some underlying “real” 
biological difference that shapes health disparities and drug reaction.130 For 
example, the chair of the FDA Cardiovascular and Renal Drugs Advisory 
 
123.  Kahn, Race in a Bottle, supra note 108, at 42 (noting that the trials were “designed not to 
meet the regulatory standards for FDA approval but to test the hypothesis that vasodilators could treat 
heart failure”). 
124.  Id. 
125.  Id. at 42–43. 
126.  Id. at 42. 
127.  Id. 
128.  Id. 
129.  In fact, Cohn has said that he prescribes BiDil to some of his White patients, noting, “I 
actually think everybody should be using it.” Denise Gellene, Heart Pill Intended Only For Blacks 
Sparks Debate, L.A. TIMES, June 16, 2005, http://articles.latimes.com/2005/jun/16/business/fi-bidil16. 
130.  BiDil African-American Subset is Surrogate for Genomics, Cmte Chair Says, 67 THE PINK 
SHEET 3, 3 (2005). 
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Committee, which endorsed BiDil’s approval, noted that the committee 
treated self-identified race in the A-HeFT trial as “a surrogate for genomic 
based medicine,”131 although no genetic data was presented to the 
committee.132 
2. The Science Behind Race-Based Medicine 
Although BiDil’s clinical trials did not identify the genetic variations 
that produce racial disparities in heart failure mortality or those that lead 
BiDil to work better in Black populations, the drug was nonetheless 
heralded as the first in a long line of ostensibly forthcoming personalized 
medicines.133 Truly personalized medicines are the province of the 
emerging field of pharmacogenomics, which studies how individual genetic 
variations might affect persons with a particular genetic makeup.134 
Individuals’ genetic sequences contain strings of nucleic acids (Adenine, 
Thymine, Cytosine, and Guanine) that may be similar for several hundred 
bases.135 They will differ at about one in every 1200 bases;136 one person 
might have, for example, Thymine at a particular location instead of 
Cytosine. These genetic variations are known as alleles, and an individual’s 
collection of alleles or genetic variations make up their genotype.137 
Understanding the location and effects of these genetic variations is 
important because they can affect drug toxicity, predict the efficacy of 
certain therapies, and identify useful drug targets.138 
Patient-specific treatments have not developed as quickly as 
researchers and academics anticipated. It is in this context that researchers 
have tried to develop genetically tailored medications at a further level of 
 
131.  Id. 
132.  See id. 
133.  For example, the New York Times began their story about the FDA’s approval of BiDil by 
noting, “The Food and Drug Administration took a controversial step toward a new frontier of 
personalized medicine yesterday, approving the first drug ever intended for one racial group, African-
Americans.” Stephanie Saul, F.D.A. Approves a Heart Drug for African-Americans, N.Y. TIMES, June 
24, 2005, at C2. 
134.  William E. Evans & Mary V. Relling, Moving Towards Individualized Medicine With 
Pharmacogenomics, 429 NATURE 464 (2004). 
135.  See The New Genetics: Chapter 1: How Genes Work, NAT’L INST. GEN. MED.SCI., 
http://publications.nigms.nih.gov/thenewgenetics/chapter1.html (last reviewed June 9, 2011). 
136.  What Is The HapMap?, INTERNATIONAL HAPMAP PROJECT, 
http://hapmap.ncbi.nlm.nih.gov/whatishapmap.html. 
137.  See Genotype: Talking Glossary of Genetic Terms, GENOME.GOV, 
https://www.genome.gov/Glossary/index.cfm?id=93 (last visited Dec. 2, 2012). 
138.  “One of the most promising areas of genomic medicine is the ability to match an 
individual’s genetic profile to the likely effect of particular drugs.” Kathy L. Hudson, Genomics, Health 
Care, and Society, 365 NEW ENG. J. MED. 1033, 1036 (2011). 
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abstraction to target specific populations instead of individuals.139 
Population geneticists’ ability to identify the sets of alleles that tend to be 
inherited together in specific groups identifiable by social categories of 
race is merging with pharmacogenomicists’ interest in determining the 
alleles that affect drug efficacy and response. This gives biomedicine the 
presumed ability to use race as a proxy for population-specific variants that 
might identify which groups respond best to certain medications or genetic 
interventions. 
3. Risks and Benefits of Race-Based Medicines 
Racial disparities in health are real and persistent.140 As such, race-
based medicine provides one potential avenue to resolve these disparities 
when other efforts simply are not able to address the problem. This partly 
explains why many groups claiming to represent the African American 
community were excited by BiDil’s FDA approval, including the NAACP 
and the Association of Black Cardiologists.141 
But with such strong claims about the biological significance of race, 
it is important to look closely at BiDil as a case study on the questionable 
premises underlying race-based medicine. First, the moral impetus 
justifying a race-specific approach to resolving heart failure—the 
commonly cited 2:1 disparity in heart failure outcomes between Blacks and 
Whites—is simply inaccurate. For example, NitroMed announced in a 2001 
press release that it had received a letter from the FDA affirming BiDil’s 
ability to be approved as a new race-specific drug.142 The release said that 
“death rates from heart failure are more than twice as high in black patients 
than in white patients” and speculated that this disparity may be caused by 
“a pathophysiology found primarily in black patients that may involve 
nitric oxide (NO) insufficiency.”143 This disparity, and NitroMed’s 
speculation concerning its biological underpinnings, were then repeated in 
various media outlets.144 
 
139.  See, e.g., Esteban Burchard et al., The Importance of Race and Ethnic Background in 
Biomedical Research and Clinical Practice, 348 NEW ENG. J. MED. 1170 (2003). 
140.  See Addressing Racial and Ethnic Disparities in Health Care Fact Sheet, U.S. DEP’T FOR 
HEALTH & HUM. SERVS. AGENCY FOR HEALTHCARE RES. & QUALITY, 
http://www.ahrq.gov/research/disparit.htm (last visited Dec. 2, 2012). 
141.  Juan Cofield, President of the New England Area NAACP chapter, has publically stated “I 
would like to see the name BiDil as common in our community as Viagra is in the general public.” Dan 
Devine, NAACP Goes to the Grassroots for BiDil, BAY ST. BANNER (Oct. 5, 2006), 
http://www.baystate-banner.com/archives/stories/2006/10/100506-07.htm. 
142.  Kahn, Getting the Numbers Right, supra note 111, at 474. 
143.  Id. (quoting the 2001 NitroMed press release). 
144.  Id. at 475 (surveying various publications that had reprinted the 2:1 ratio). 
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But, a closer look at the data suggests that there is no significant racial 
disparity in heart failure outcomes. In fact, the 2:1 number comes from a 
string of misquotes referencing decades-old data.145 In 1998 the CDC 
placed the ratio at 1.1:1, which essentially means that there is no racial 
difference in outcomes.146 NitroMed later revised its claim to say, “The 
African-American community is affected at a greater rate by heart failure 
than that of the corresponding Caucasian population. African Americans 
between the ages of 45 and 64 are 2.5 times more likely to die from heart 
failure than Caucasians in the same age range.”147 Though this is accurate, 
“[t]he age group 45 to 64 only accounts for about 6% of heart failure 
mortality, and for those over 65, the statistical differences between ‘African 
Americans and Caucasians’ nearly completely disappear.”148 These 
findings significantly undermine the moral justification for a race-specific 
approach. 
Second, the design of the A-HeFT clinical trial used to demonstrate 
BiDil’s race specific impact was flawed. By only enrolling patients that 
self-identified as African American without any comparison group, the 
clinical trial, by definition, cannot speak to whether the drug works better 
in one group than another. As law professor Jonathan Kahn notes, “[t]he 
only responsible scientific claim that can be made on the basis of these 
trials is that BiDil works in some people who have heart failure, period.”149 
The FDA has vigorously defended its decision to approve BiDil’s race-
specific labeling and the evidence from A-HeFT used to justify this 
decision.150 Scientists for the FDA said that conducting a separate trial to 
specifically compare outcomes between Blacks and Whites “would have 
required years of work, many thousands of patients, and wholly 
unreasonable delay in approval of a treatment whose effectiveness had 
 
145.  Id. at 475–78. 
146.  Changes in Mortality from Heart Failure—United States, 1980–1995, MMWR, Aug. 7, 
1998, at 633-37. See also Kahn, Getting the Numbers Right, supra note 111, at 473–74. 
147.  Press Release, NitroMed, Inc., BiDil(R) Named to American Heart Association’s 2004 ‘Top 
10 Advances’ List (Jan. 11, 2005), available at http://www.prnewswire.com/news-releases/bidilr-
named-to-american-heart-associations-2004-top-10-advances-list-54001632.html. 
148.  Troy Duster, Race and Reification in Science, 307 SCIENCE 1050, 1050 (2005). 
149.  Kahn, From Disparity to Difference, supra note 120, at 106. 
150.  Two FDA scientists, Robert Temple and Norman Stockbridge, wrote in the Annals of 
Internal Medicine: 
Approval of BiDil was not based on a single trial where all data came from the black patient 
population, as has been suggested. The FDA’s encouragement of A-HeFT, a single-
population trial, arose from recognition that a larger study of black and white patients was 
not likely to yield any additional useful information. 
Robert Temple & Norman L. Stockbridge, BiDil for Heart Failure in Black Patients: The U.S. Food 
and Drug Administration Perspective, 146 ANNALS INTERNAL MED. 57, 58 (2007). 
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been well-documented in the group for which it was intended.”151 
However, this defense only further highlights the FDA’s assumptions 
regarding the biological significance of race when such drug approval 
determinations should be based on stronger and more direct evidence. 
Third, the assumption that social categories of race can be used as a 
proxy for significant genetic variation at the population level is flawed. The 
connection between social categories of race and population differences is 
unfounded. There are certainly genetic differences between population 
groups as a result of various dynamics (such as migration and reproduction) 
that may lead certain markers to appear more often in particular groups. 
But it is a large leap to suggest that these population dynamics 
meaningfully align with social categories of race, especially when the 
meaning and salience of these categories stem from social, political, and 
economic factors. Francis Collins, former director of the National Institutes 
of Health, argues: 
“Race” and “ethnicity” are poorly defined terms that serve as flawed 
surrogates for multiple environmental and genetic factors in disease 
causation, including ancestral geographic origins, socioeconomic status, 
education and access to health care. Research must move beyond these 
weak and imperfect proxy relationships to define the more proximate 
factors that influence health.152 
The concerns associated with BiDil’s FDA approval highlight three 
broader issues raised by race-based medicines that may belie the effort to 
reduce health disparities. First, the emphasis placed on reducing health 
disparities through genetic interventions can obscure known social 
determinants of health outcomes. A substantial body of evidence has shown 
that “[f]actors such as income and education, and how they play out in 
housing and neighborhood, directly exert a powerful influence on health 
disparities in the United States—potentially as powerful as medical care or 
genetics.”153 High profile cases such as BiDil draw substantial attention 
and many dollars toward speculating about the possible genetic causes of 
health disparities when those resources could be better allocated to address 
known social factors that can be improved to reduce gaps in health 
outcomes. 
 
151.  Id. at 57. 
152.  Francis S Collins, What We Do and Don’t Know About ‘Race,’ ‘Ethnicity,’ Genetics and 
Health at the Dawn of the Genomic Era, 36 NATURE GENETICS SUPP. S13, S13 (2004). 
153.  ROBERT WOOD JOHNSON FOUND., OVERCOMING OBSTACLES TO HEALTH: STORIES, FACTS 
AND FINDINGS 3 (2008), available at http://www.commissiononhealth.org/PDF/ObstaclesToHealth-
Highlights.pdf. 
OBASOGIE FINAL V3 2/26/2013  1:33 PM 
30 Southern California Interdisciplinary Law Journal  [Vol. 22:1 
 
This leads to the second concern that continued speculation 
concerning the biological roots of racial disparities in health may shift 
responsibility for remediation from sustained public health initiatives to 
private biomedical ventures. As demonstrated by BiDil’s transformation 
from a race-neutral to a race-specific drug, commercial incentives can lead 
to premature and unsubstantiated articulations of biological race, which go 
against the public interest. Third, weak claims about the biological 
relevance of racial disparities in health can prematurely legitimize 
biological explanations of racial disparities in other areas such as aptitude 
and criminality, which ultimately disserve minority communities. 
B. GENETIC ANCESTRY TESTS 
1. Claims Made 
Genetic ancestry tests are part of a growing field of what some 
academics have called “recreational genetics,” where individuals use 
direct-to-consumer genetic tests to learn about their genetic predispositions 
without direct interactions with medical professionals.154 Some of these 
tests are health-related, but a growing number are recreational in the most 
literal sense. For example, Atlas Sports Genetics offers a test that allows 
parents to determine the sports in which their child might be genetically 
predisposed to excel.155 Genetic ancestry tests have developed within this 
burgeoning market to give individuals a better sense of their racial and 
ethnic heritage.156 Companies that provide this service have amassed 
databases containing genetic information from indigenous populations 
around the globe and compare individuals’ genetic markers to these 
reference populations in order to find similarities that suggest an ancestral 
link.157 
Genetic ancestry companies often make fantastic claims about their 
ability to precisely link consumers’ genes to past ancestors in a manner that 
provides robust insight into their identity and heritage.158 These claims 
 
154.  Deborah A. Bolnick et al., The Science and Business of Genetic Ancestry Testing, 318 SCI. 
399, 399 (2007). 
155.  Juliet Macur, Born to Run? Little Ones Get Tested for Sports Gene, N.Y. TIMES, Nov. 30, 
2008, http://www.nytimes.com/2008/11/30/sports/30genetics.html. This test “is done by swabbing the 
inside of the child’s cheek to obtain a DNA sample that is then returned to a lab for analysis for 
ACTN3, one of the more than 20,000 genes that make up the human genome. A 2003 study linked 
ACNT3 to athletic performance.” Id. See also What is ACTN Sports Gene?, ATLAS SPORTS GENETICS, 
http://www.atlasgene.com (last visited Dec. 2, 2012). 
156. Bolnick et al., supra note 154, at 399. 
157.  Id. 
158.  E.g., The Story Behind Your Y-DNA (Male Ancestry), DNA WORLDWIDE, 
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have led nearly half-a-million people to purchase these tests since 2002.159 
Moreover, these tests have been used for a variety of purposes beyond pure 
recreation. For example, individuals who otherwise identify as White have 
used these tests to show that they have some meaningful amount of shared 
genetic ancestry with a minority group in order to increase their chances of 
being admitted to a university under an affirmative action program or to be 
eligible for financial aid intended for minority students.160 Individuals have 
also claimed to be Native American so that they can partake in various 
benefits and opportunities reserved for established Native tribes.161 Indeed, 
several companies market specifically to Native Americans.162 
African Americans are also targeted by genetic ancestry companies. 
Given that many African Americans cannot trace their ancestry back more 
than a few generations due to the slave trade, ancestry testing is seen as a 
way to surpass history’s roadblocks to give Black Americans a sense of 
their ancestral linkage to the African continent.163 This can have a 
tremendous impact on Blacks’ sense of identity.164 
 
http://www.dna-worldwide.com/ancestry-testing/male-ancestry/male-dna-story (last visited Dec. 2, 
2012) (claiming that “Your Y-chromosome made you the man you are today. Quite literally. It contains 
the genetic switch that sent you down the path of turning you into a baby boy. But before it reached 
you, your Y-chromosome had been on an incredible journey”). 
159.  Troy Duster, Ancestry Testing and DNA: Uses, Limits, and Caveat Emptor, in RACE AND 
THE GENETIC REVOLUTION: SCIENCE, MYTH, AND CULTURE 99, 99 (Sheldon Krimsky & Kathleen 
Sloan eds., 2011). 
160.  Amy Harmon, Seeking Ancestry in DNA Ties Uncovered by Tests, N.Y. TIMES, Apr. 12, 
2006, http://www.nytimes.com/2006/04/12/us/12genes.html. 
161.  Kim TallBear & Deborah A. Bolnick, Native American DNA Tests: What Are the Risks to 
Tribes?, NATIVE VOICE, Dec. 3–7, 2004, at D2. 
162.  Genelex, a company that offers genetic ancestry tests, ran this advertisement in Indian 
Country Today, a newsmagazine for Native Americans: 
Do you need to confirm that you are of Native American descent? Recent advances in 
genetic ancestry testing have put the answer to this question at your fingertips. Whether your 
goal is to assist in validating your eligibility for government entitlements such as Native 
American Rights or just to satisfy your curiosity, our Ancestry DNA test is the only 
scientifically rigorous method available for this purpose in existence today. 
Kimberly TallBear, Native-American-DNA.com, in REVISING RACE IN A GENOMIC AGE 235, 243 
(Barbra A. Koenig, Sandra Soo-Jin Lee & Sarah S. Richardson eds., 2008). 
163.  Bolnick et al., supra note 154, at 399. 
164.  In the PBS special African-American Lives, the results of ancestry tests were revealed to 
several Black celebrities. When told that these tests could tell her about her heritage, Whoopi Goldberg 
exclaimed, “It’s possible to find out what I am and who I am and what part? Oh my goodness!” The 
results, however, are not always positive. When Oprah Winfrey’s results showed that she was not Zulu, 
as she has previously believed, she was visibly disappointed. African-American Lives (PBS television 
broadcast Feb. 2006). 
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2. The Science Behind Genetic Ancestry Tests 
Genetic ancestry testing can be understood as the commercial iteration 
of scholarly research in population genetics, a field that examines how 
evolutionary forces, such as migration and reproduction, shape the 
distribution and frequency of various genes within particular 
populations.165 Over time, these evolutionary dynamics can lead certain 
markers to become strongly associated with the group itself.166 This uneven 
distribution of genetic markers can provide clues to their geographic 
origins, which can then point to the most closely associated population.167 
Several large scale attempts, including the International HapMap Project168 
and the Human Genome Diversity Project,169 have tried to map the genetic 
variations most closely linked to global human populations in a manner that 
ultimately gives greater biological coherence to social categories of race. 
An increasing amount of research is beginning to demonstrate 
connections between population differences and racial groupings. Esteban 
Burchard and his colleagues note, “Studies in population genetics have 
revealed great genetic variation within racial or ethnic subpopulations, but 
also substantial variation among the five major racial groups.”170 This has 
been demonstrated in at least three types of studies. First, population 
geneticists studying global indigenous groups have created ancestral tree 
diagrams “showing that the human population has major branches 
corresponding to the major racial groups, with sub-branches within each 
racial group associated with indigenous groups.”171 Second, researchers 
have used cluster analyses that look for patterns of similarity between 
population groups that “have . . . consistently resulted in the delineation of 
 
165.  See L.L. Cavalli-Sforza et al., Call for a Worldwide Survey of Human Genetic Diversity: A 
Vanishing Opportunity for the Human Genome Project, 11 GENOMICS 490, 490 (1991). 
166.  See id. 
167.  Id. 
168.  The goal of the International HapMap Project is to “determine the common patterns of DNA 
sequence variation in the human genome and to make this information freely available in the public 
domain.” Int’l HapMap Consortium, The International HapMap Project, 426 NATURE 789, 789 (2003). 
169.  In his article outlining the origins and development of the Human Genome Diversity Project, 
Cavalli-Sforza explains that the “Human Genome Diversity Project (HGDP) provides a resource that is 
aimed at promoting worldwide research on human genetic diversity, with the ultimate goal of 
understanding how and when patterns of diversity were formed.” L. Luca Cavalli-Sforza, The Human 
Genome Diversity Project: Past, Present and Future, 6 NAT. REV. GENETICS 333, 333 (2005). Cavalli-
Sforza also notes that the HGPD “has the added benefit of providing information that is likely to prove 
useful to several areas of biomedical research.” Id. 
170.  Esteban González Burchard et al., The Importance of Race and Ethnic Background in 
Biomedical Research and Clinical Practice, 348 NEW ENG. J. MED. 1170, 1172 (2003). These five 
major groups include “African American, White, Asian, native Hawaiian or other Pacific Islanders, and 
American Indian or Alaska native.” Id. 
171.  Id. 
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major genetic clusters that are associated with racial categories.”172 Third, 
studies that look at the distribution of genetic variations across racial 
groups have been able to identify variants that are more likely to be race-
specific.173 As a whole, these three groups of studies provide the scholarly 
architecture to frame some population geneticists’ assertion that social 
categories of race are meaningful and observable at the molecular level. 
Working from these insights, genetic ancestry companies typically use 
three types of techniques to deduce individuals’ ancestry. First, 
mitochondrial DNA (“mtDNA”) tests focus on the DNA passed 
specifically from mother to child to test maternal links.174 Second, Y-
chromosome tests determine paternal ancestry by examining markers 
passed from father to son.175 Last, admixture tests look at markers on non-
sex chromosomes containing DNA contributions from both parents to 
provide percentages of a person’s ancestry from each of the five main 
continental groups.176 
With mtDNA and Y-chromosome testing, companies can determine 
consumers’ ancestry by comparing the individuals’ haplotypes (a set of 
associated variations) to the haplotypes from samples taken from groups 
indigenous to a particular geographic location.177 This method is useful for 
determining whether any two people are related. In the ancestry-testing 
context, however, it is used to link individuals to certain populations in 
order to estimate the geographic origins of their genetic makeup.178 In 
contrast, admixture mapping looks at 175 autosomal markers, which are 
genetic variants thought to be closely related to particular continental 
populations.179 The genetic variants chosen to identify individual ancestry, 
 
172.  Id. 
173.  Id. Burchard and his co-authors explain: 
Allele[s] with a frequency of 20 percent or greater in one racial group, the odds are in favor 
of seeing the same variant in another racial group. However, variants with a frequency 
below that level are more likely to be race-specific. This race-specificity of variants is 
particularly common among Africans, who display greater genetic variability than other 
racial groups and have a larger number of low-frequency alleles. These results indicate that 
the frequency of variant alleles underlying disease or normal phenotypes can vary 
substantially among racial groups, leading to differences in the frequency of the phenotypes 
themselves. 
Id. (citation omitted). 
174.  Bolnick et al., supra note 154, at 399. 
175.  Id. 
176.  Id. 
177.  Id. 
178.  Id. 
179.  Id. 
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known as Ancestry Informative Markers (“AIM”),180 are “those that have 
the most uniqueness, or the largest differences in allele frequency among 
populations.”181 For example, a company’s database of genetic samples 
from populations across the globe might show that an individual shares 
markers with groups from East Asia but not Europe, leading to test results 
that suggest the individual has Asian ancestry. Admixture tests focus on the 
relatively few genetic markers that are seemingly connected to specific 
populations and are thought to provide a better overall sense of a person’s 
ancestry.182 
3. Risks and Benefits of Genetic Ancestry Testing 
Genetic ancestry tests have the potential benefit of giving individuals 
a better sense of their ancestry and racial heritage, which can be quite 
fulfilling for people who feel disconnected from a larger community. 
However, these technologies’ scientific limitations, along with the often 
questionable marketing claims made to consumers, suggest that these tests 
risk reinventing biological race in new but no less problematic terms. For 
example, while genetic ancestry testing companies often resist using the 
word “race” in favor of terms such as “biogeographical ancestry,” it is not 
uncommon for users to consider these products to be tests of racial purity 
and mixture.183 
Concerns about genetic ancestry tests start with the often unnoticed 
gap or logical leap between scholarly conversations about population-wide 
genetic differences and the ability of tests to meaningfully reveal 
individuals’ ancestral origins. The genetic boundaries that may appear to 
mark population differences are not clear-cut, making the interpretation of 
individual ancestry even more problematic. Anthropologist Deborah 
Bolnick notes that although ancestry tests “emphasize[] the individual as 
the crucial unit of analysis, individual ancestry inference is closely tied to 
our understanding of human groups and the distribution of genetic 
variation among them.”184 This broad concern shapes the critique of 
particular techniques used to determine individual ancestry. Mitochondrial 
 
180.  Id. at 400. 
181.  ANTHONY FRUDAKIS, MOLECULAR PHOTOFITTING 44 (2008). 
182.  See Bolnick et al., supra note 154, at 399. 
183.  See, e.g., U.S. Patent Application No. 10/644,594, at 233 (filed Nov. 18, 2004) (using the 
term “biogeographical ancestry” in a patent application for an admixture test). 
184.  Bolnick et al., supra note 154, at 399. The authors also point out that it is impossible to link 
an individual’s DNA to that of a larger group “unless one first distinguishes groups that differ 
genetically in some way. Thus, even such individually oriented genetic research has implications for 
our understanding of race and the pattern of human biological diversity.” Id. 
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and Y-chromosome testing examine only a very small portion of an 
individual’s genome—a thin slice of the diverse genetic contributions that 
we receive from our parents, grandparents, great-grandparents, and so 
forth.185 For example, if an individual goes back nine generations, there are 
512 great-great-great-great-great-great-great-grandparents who are each 
equally influential to that person’s genetic makeup. However, 
mitochondrial and Y-chromosome testing, taken together, can only provide 
information for two of these individuals: the strain of genetic information 
passed on from mother to child and the strain that is passed on from father 
to son along the Y-chromosome. This information travels unchanged 
throughout generations (mother, maternal grandmother, maternal great-
grandmother, etc. and father, paternal grandfather, and paternal great-
grandfather, etc.) and only represents information for two ancestors even 
though the number of overall ancestors contributing to a person’s genome 
doubles each generation.186 If each of an individual’s ancestors contributes 
equally to his or her genetic make-up, why emphasize the information 
gleaned from only two of them through mitochondrial and Y-chromosome 
testing? In the example where we go back nine generations with 512 
individuals contributing to a person’s genetic makeup, what about the other 
510 people? Although genetic ancestry companies market their 
mitochondrial and Y-chromosome tests as being able to tell individuals 
something definitive about their race or ancestry, they are only able to 
examine less than 1 percent of a person’s genetic background.187 Thus, the 
strength of the assertions made by the genetic ancestry companies often 
does not acknowledge these significant limitations. 
Admixture testing is thought to resolve these problems because it 
looks at genetic markers that are influenced by both parents, providing a 
blend of information that goes beyond that available through mitochondrial 
and Y-chromosome testing.188 But admixture testing discusses ancestry in 
terms of percentages; for example, reporting that someone is 85 percent 
European and 15 percent African.189 This presumes that racial purity 
existed at some prior point in a manner that mirrors the long-discredited 
polygenesis theory. This can mislead individuals into thinking that 
biologically distinct racial groups are real and that social categories of race 
 
185.  Id. 
186.  See id. 
187.  Id. 
188.  See id. 
189.  Id. at 400. 
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have meaning at the molecular level.190 Moreover, the biological difference 
between racial groups that admixture testing purports to objectively 
discover is actually the motivating assumption behind these tests’ 
configuration. Anthropologist Duana Fullwiley provides a startling 
example by demonstrating how one now-defunct ancestry company 
collected and interpreted its data: 
[T]he very continents and peoples chosen for [DNAPrint’s AIMs] product 
were selected due to their perceived proximity to what we in North 
America imagine race to be. Although the language of scientists who 
invented this panel of AIMs is now that of “biogeographical ancestry,” the 
conceptual configuration of human racial typology remains intact.191 
These residual notions of racial typology are further evidenced by the 
company’s patent application for its admixture test, where it 
euphemistically defines “BioGeographical Ancestry” as “the heritable 
component of ‘race.’”192 
In addition to these concerns about technique, genetic ancestry testing 
as a whole raises several broader issues. First, very few, if any, genetic 
variations appear only within socially defined racial groups.193 Researchers 
may be able to show the frequency of particular variations in certain 
populations, but connecting an individual to a specific group—such as a 
socially-defined racial group—is a process fraught with potentially perilous 
assumptions.194 These variations have yet to be shown to map precisely 
onto social categories of race—categories that are typically defined by 
 
190.  See id. Bolnick and her co-authors note that admixture test creates “the appearance of 
genetically distinct populations,” by focusing on “ancestry informative markers” (“AIMs”) that are 
believed to be indicative of specific “parental” populations. Id. However, the development of these 
“parental” populations seems to have been artificially selected, and there is little evidence that such 
“parental” populations ever existed. Id. 
191.  Duana Fullwiley, The Biologistical Construction of Race: ‘Admixture’ Technology and the 
New Genetic Medicine, 38 SOC. STUDIES OF SCI., 695, 706 (2008). See also Duana Fullwiley, Can DNA 
‘Witness’ Race? Forensic Uses of an Imperfect Ancestry Testing Technology, COUNCIL FOR 
RESPONSIBLE GENETICS (2008), 
http://dash.harvard.edu/bitstream/handle/1/3008240/Fullwiley_DNAWitnessRace.pdf (providing an 
illuminating discussion about how the assumptions behind the construction of AIMs as markers drives 
the findings of individuals’ ancestry in a manner that reflects a distinctively American understanding of 
racial typology). 
192.  U.S. Patent Application No. 10/644,594, at [007] (filed Nov. 18, 2004). 
193.  Bolnick et al., supra note 154, at 400. 
194.  Id. Bolnick and her co-authors note that the companies that create these tests are quick to 
link the occurrence of a certain allele or haplotype with a particular population, despite the fact that 
“high genetic diversity exists within populations and gene flow occurs between populations.” Id. 
Additionally, these companies “sometimes fail to mention that an allele could have been inherited from 
a population in which it is less common,” and consumers are not made aware of the potential 
shortcomings of these tests. Id. (internal citation omitted). 
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physical appearance, political forces, and other social conventions.195 
Given that these tests examine less than 1 percent of a person’s genetic 
background, there can be a tremendous gap between the limited 
information conveyed by these tests and how consumers interpret the 
findings.196 
Second, the results a company gives to consumers about their racial or 
ancestral backgrounds are only as useful as the database samples compiled 
by the company.197 The business of genetic ancestry testing relies entirely 
on comparing individual profiles against a database made up of relatively 
small samples of populations from across the globe.198 These databases 
serve as genetic reference points under the assumption that the profiles in 
the database reflect a reasonable spectrum of human genetic diversity.199 
But these commercial databases are far from reflecting the true range of 
genetic diversity across global populations.200 Just because an individual 
“matches” in one location does not mean that he or she does not match in 
others.201 This, in part, explains why it is not uncommon for individuals 
who take multiple tests to receive different results.202 
The third and final issue is that the claims made by genetic ancestry 
companies are often not supported by the available science. It is not 
uncommon for companies to make bold statements about their ability to 
accurately pinpoint a person’s ancestry. For example, an advertisement by 
Genetic Testing Laboratories (“GTL”) claims that its Ancestral Origins 
DNA Ancestry Testing Service can “[d]iscover your [anthropological] 
links. . . . [T]his simple DNA Ancestry test . . . illustrates your unique 
geogenetic heritage from both a per-population view, and an overall 
regional view.”203 However, claims such as these can mislead consumers 
because they neglect to reveal that “present-day patterns of residence are 
rarely identical to what existed in the past, and social groups have changed 
 
195.  Id. 
196.  Id. at 399. 
197.  Id. 
198.  “[E]ven databases with 10,000 to 20,000 samples may fail to capture the full array of human 
genetic diversity in a particular population or region.” Id. 
199.  Id. 
200.  See id. Bolnick and her co-authors point out that, while these tests can identify “some of the 
groups and locations around the world” a test-taker shares genetic similarities with, they are “unlikely 
to identify all of them.” Id. 
201.  Id. at 400. 
202.  See Ron Nixon, DNA Tests Find Branches But Few Roots, N.Y. TIMES, Nov. 25, 2007, at 3-
1. 
203.  Ancestral Origins DNA Ancestry Testing, GENETIC TESTING LABORATORIES, 
https://www.gtldna.net/ancestral-origins-dna-ancestry.html (last visited Oct. 24, 2011). 
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over time, [both] in name and composition. Databases of present-day 
samples may therefore provide false leads.”204 Bolnick and her co-authors 
note: 
Worldwide patterns of human genetic diversity are weakly correlated with 
racial and ethnic categories because both are partially correlated with 
geography. Current understandings of race  and ethnicity reflect 
more than genetic relatedness, though, having been defined in particular 
sociohistorical contexts (i.e., European and American colonialism). In 
addition, social  relationships and life experiences have been as 
important as biological ancestry in shaping individual identity and group 
membership.205 
Thus, it is not only scientifically imprecise to use contemporary racial 
categories and population distribution as reference points to understand 
past identities and locations, but it also contradicts current scholarly 
understandings concerning migration patterns and other evolutionary and 
sociological dynamics. 
C. DNA FORENSICS 
1. Claims Made 
Criminal investigators have used scientific evidence to identify and 
convict criminals for centuries.206 However, when DNA technologies were 
introduced in the 1980s for forensic purposes, scholars and the courts met 
them with substantial skepticism.207 Traditional forensic approaches such 
as latent fingerprinting were seen as more trustworthy and certain than 
DNA technologies.208 Fast-forward three decades and the converse is true: 
DNA is now the gold standard of evidence.209 This shift toward 
overvaluing DNA evidence has been so profound that some worry about a 
“CSI effect,” where prosecutors find it increasingly difficult to secure a 
 
204.  Bolnick et al., supra note 154, at 400 (internal citation omitted). 
205.  Id. (internal citation omitted). 
206.  Am. Coll. of Forensic Examiners, 1248 Early Forensic Study, HISTORY OF FORENSICS, 
http://historyofforensics.com (last visited Dec. 2, 2012). 
207.  Michael Lynch, God’s Signature: DNA Profiling, the New Gold Standard in Forensic 
Science, 27 ENDEAVOR 93, 93 (2003). 
208.  See id. 
209.  Michael Lynch, professor of Science and Technology Studies at Cornell University, suggests 
that “[t]he acceptance of DNA profiling as a certain, error-free method of personal identification has 
profoundly influenced the degree of trust invested in it, compared with other forms of criminological 
evidence.” Id. Additionally, forms of evidence that had long been used to show guilt, such as 
“handwriting analysis, lie detector tests, fiber analysis, ballistics, blood-spatter analysis, [and] bite-mark 
analysis,” have now been “called into question in comparison with the new ‘gold standard’ of DNA 
profiling.” Id. at 93–94. 
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conviction without offering DNA evidence to a jury.210 The definitive 
claim made across all forensic techniques involving DNA is that it is a 
virtually infallible arbiter of identifying subjects to determine their guilt or 
innocence. 
2. The Science Behind DNA Forensics 
Humans are over 99 percent similar to one another in terms of their 
genetic makeup.211 However, the less-than 1 percent difference remaining 
represents millions of individual points of genetic variation that can be used 
to uniquely identify individuals.212 Buried within our genomes are 
chromosomal regions called loci. Loci are sites for short tandem repeats 
(“STRs”)—“stretches of DNA where the DNA replicating mechanism 
appears to ‘stutter,’ resulting in different numbers of copies of repeated 
sequences.”213 A four-base sequence such as CGAT might repeat several 
times at a locus; each sequence and its repetition is considered a variant.214 
These variants mark nearby genes because their location on the 
chromosome is known; a person’s unique genetic profile can be deduced by 
the number of variants across a particular set of chromosomal loci.215 
Accuracy in DNA testing is improved by checking a greater number of 
loci.216 Thirteen loci is the U.S. federal government’s standard for 
identification; the chance that two unrelated individuals coincidentally 
match at all thirteen locations is astronomically low—one in several 
billion.217 Since biological samples can be amplified, only trace amounts of 
blood or saliva left at a crime scene are needed to make comparisons to 
known profiles.218 Polymerase chain reaction (“PCR”) is a technique that 
can be used to mimic cells’ natural replication process in order to generate 
 
210.  Michael Mann, Student Article, The “CSI Effect”: Better Jurors Through Television and 
Science?, 24 BUFF. PUB. INT. L.J. 211, 214–15 (2006). The “CSI effect,” named after the syndicated 
television show, has led many people to think that “scientific evidence is available and irrefutable in 
every criminal proceeding.” Id. This may lead some jurors to have “heightened expectation of what they 
will see when they enter a courtroom,” and often leaves them looking for this type of definitive 
scientific evidence in real life cases. Id. 
211.  ROCHE, GENES AND HEALTH (2007), available at 
http://www.roche.com/genes_and_health.pdf. 
212.  Id. 
213.  Henry T. Greely et al., Family Ties: The Use of DNA Offender Databases to Catch 
Offenders’ Kin, 34 J.L. MED. & ETHICS 248, 249 (2006). 
214.  Id. at 249–50. 
215.  Id. at 250. 
216.  See id. 
217.  Id. 
218.  See DAVID H. KAYE, THE DOUBLE HELIX AND THE LAW OF EVIDENCE 180 (2010). 
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enough cellular material from trace amounts to make adequate 
comparisons.219 
Although DNA typing is typically very reliable, several problems can 
arise related to the handling and interpretation of the evidence, which can 
shape overall determinations of an individual’s guilt or innocence.220 This 
includes problems with contamination (mixing of samples), clerical errors, 
misinterpreting old or small samples, or coincidental matches.221 It is useful 
to take a closer look at DNA forensics’ various applications in order to 
appreciate the different techniques used to identify criminals and how this 
might aggravate concerns pertaining to the reemergence of biological race. 
a. DNA Databases 
Since the 1990s, DNA databases have been used by local, state, and 
federal law enforcement to store convicted criminals’ genetic profiles.222 
This approach has been the most widespread in the United Kingdom where 
genetic profiles of nearly 8 percent of the population (4.9 million people) 
are on file.223 This figure represents the United Kingdom’s aggressive 
policy of retaining profiles from anyone detained by the police.224 In the 
early days of DNA forensics, the United States only retained profiles from 
individuals convicted of serious felonies such as rape.225 In 1998, the FBI 
launched CODIS, which is a federal repository for offenders’ genetic 
profiles that shares information with state and local databases.226 Every 
state now has statutory provisions permitting the collection of DNA from 
suspects or convicts.227 The bar for inclusion varies; at least thirty-four 
states authorize retaining DNA from individuals convicted of any felony, 
 
219.  Id. at 178–91. 
220.  See infra Part III.C.2.a. 
221.  See infra Part IV.B. 
222.  Helen Wallace, Prejudice, Stigma, and DNA Databases, in RACE AND THE GENETIC 
REVOLUTION: SCIENCE, MYTH, AND CULTURE 68, 68 (Sheldon Rimsky & Kathleen Sloan eds., 2011). 
223.  Id. at 70. 
224.  Id. at 70–72. 
225.  “State DNA databases, which began almost exclusively as collections of adult sexual 
offenders’ DNA profiles, have now expanded to include many or all convicted felons, juvenile 
offenders, those convicted of certain misdemeanors, and even arrestees.” Mark A. Rothstein & Meghan 
K. Talbott, The Expanding Use of DNA in Law Enforcement: What Role for Privacy? 34 J.L. MED. & 
ETHICS 153, 153 (2006). 
226.  What is CODIS?, DNA INITIATIVE, 
http://www.dna.gov/solving-crimes/cold-cases/howdatabasesaid/codis (last visited Dec. 2, 2012). See 
also Michael Seringhaus, Op-Ed., To Stop Crime, Share Your Genes, N.Y. TIMES, Mar. 14, 2010, at 
A23. 
227.  Seringhaus, supra note 226. 
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while at least thirty-eight states permit taking DNA samples from 
individuals convicted of certain misdemeanors.228 
Several new state and federal laws are now authorizing the retention 
of DNA from individuals merely arrested for certain crimes; DNA is kept 
on file regardless of whether the person is ever charged or convicted. For 
example, a 2006 amendment to the Violence Against Women Act allows 
the Department of Justice to retain DNA from people arrested or held by 
federal agents.229 Following this lead, thirteen states—including California, 
Kansas, and North Dakota—now collect DNA from arrestees.230 This has 
the intended effect of radically expanding the number of genetic profiles 
stored by state, local, and federal governments.231 From the perspective of 
law enforcement, including arrestees in DNA databases increases the 
chances of finding a match while posing no threat to innocent individuals 
given the precision of DNA forensics. This claim will be examined later in 
this section. 
b. Cold Hits, Partial Matches, and Familial Searches 
One presumed benefit of expanding the number of profiles in DNA 
databases through arrestee inclusion policies is the increased success of 
cold hit and partial match searches. Cold hits occur when: 
[T]he major or only evidence is biological material linking the defendant 
to the offense. In these cases, the government has no investigatory leads, 
but develops a genetic profile based upon some material left at a crime 
scene. The government then runs that forensic profile in a database and 
uncovers a “match”—a stored sample associated with a known person or 
offender.232 
With more profiles included in forensic databases, law enforcement hopes 
to increase the chances that crime scene samples with currently unknown 
identities will point toward a potential suspect. 
It is also useful to distinguish between full and partial matches. Full 
matches are the most robust; they occur when two profiles match across the 
 
228.  Seth Axelrad, Survey of State DNA Database Statutes, AM. SOC. L. MED. & ETHICS (2005), 
available at http://www.aslme.org/dna_04/grid/guide.pdf (for data, see Grid: Survey of DNA Database 
Statutes, AM. SOC. L. MED. & ETHICS, http://www.aslme.org/dna_04/grid/statute_grid.html (last visited 
Dec. 2, 2012)). 
229.  Karen J. Maschke, DNA and Law Enforcement, in FROM BIRTH TO DEATH AND BENCH TO 
CLINIC: THE HASTINGS CENTER BIOETHICS BRIEFING BOOK FOR JOURNALISTS, POLICYMAKERS, AND 
CAMPAIGNS 45, 46 (Mary Crowley ed., 2008). 
230.  Id. 
231.  Id. at 45. 
232.  Erin Murphy, The New Forensics: Criminal Justice, False Certainty, and the Second 
Generation of Scientific Evidence, 95 CALIF. L. REV. 721, 740 (2007). 
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thirteen CODIS markers.233 Partial matches occur when two profiles match 
at fewer than thirteen markers.234 Experts have testified that as few as a 
nine-locus match can be used to definitively identify someone.235 Familial 
searches leverage the fact that close relatives (such as siblings or a child 
and a parent) share half of the same short tandem repeat lengths and genetic 
variants, while uncles, aunts, and other more distant relatives share about 
one quarter.236 For example, partial matches at six or seven CODIS 
markers might not point directly to a suspect. But it might point to their 
brother or mother, which can lead investigators to the person who 
committed the crime.237 This technique was successfully used to solve the 
Grim Sleeper case, in which serial killer Lonnie Franklin—alleged to have 
murdered ten women over twenty-two years in Southern California238—
was captured by partially matching DNA from the crime scenes to a 
California prisoner, which suggested a close relative was the culprit.239 
Franklin is the prisoner’s father.240 
c. Molecular Photofitting 
New genetic technologies are using information in biological samples 
left at crime scenes to go beyond finding suspects through cold hits or 
partial matches. Technologies similar to admixture mapping are being used 
to develop descriptions of suspects’ phenotypes or physical appearances. 241 
One technology, called molecular photofitting, is an approach that attempts 
to “produce forensically (or biomedically) useful predictions of physical 
features or phenotypes from an analysis of DNA variation. . . . [to provide] 
 
233.  WILLIAM C. THOMPSON, THE POTENTIAL FOR ERROR IN FORENSIC DNA TESTING (AND 
HOW THAT COMPLICATES THE USE OF DNA DATABASES FOR CRIMINAL IDENTIFICATION), COUNCIL 
FOR RESPONSIBLE GENETICS 5 (2008), available at 
http://www.councilforresponsiblegenetics.org/pageDocuments/H4T5EOYUZI.pdf. 
234.  Id. 
235.  Id. at 21. 
236.  Greely et al., supra note 213, at 251–52. 
237.  See id. at 252. 
238.  Edecio Martinez, “Grim Sleeper” Arrest: Who is Lonnie Franklin, Jr.?, CBS NEWS (July 8, 
2010, 11:47 AM), http://www.cbsnews.com/8301-504083_162-20009945-504083.html. 
239.  David Lazer & Frederick R. Bieber, ‘Familial Searching,’ Its Promise and Perils, L.A. 
TIMES, July 10, 2010, http://articles.latimes.com/2010/jul/10/opinion/la-oe-lazer-grim-sleeper-dna-
20100710. 
240.  Id. 
241.  These technologies “have been based primarily on genetic information about a sample 
source’s recent ancestry, and to a lesser extent, on genetic information about her morphology. Forensic 
analysts use ancestry and morphology information to infer a suspect’s race and general appearance.” 
Pilar N. Ossorio, About Face: Forensic Genetic Testing for Race and Visible Traits, 34 J.L. MED. & 
ETHICS 277, 281 (2006). 
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a summary list of physical traits like height, weight, hair color, eye color, 
and race, and a fuzzy or low-resolution photograph.”242 
This technology was used to capture another serial killer, Derrick 
Todd Lee.243 Eyewitness accounts, along with previous studies showing 
that most serial killers are White, suggested that the person responsible for 
several murders in Baton Rouge, Louisiana, was a White male.244 
However, researchers at the now-defunct245 DNAPrint Genomics used this 
technology to assess the ancestry informative markers of the biological 
sample left at a crime scene.246 Their findings suggested that the suspect 
was not White, but a light-skinned Black man—one with 85 percent 
African and 15 percent Native American ancestry.247 This reoriented law 
enforcement’s search, leading to Lee’s arrest and conviction.248 
 
Figure 2: On the left is a police sketch of Baton Rouge serial killer, based 
on eyewitness accounts. On the right is convicted serial killer Derrick Todd 
Lee.249 
 
242. FRUDAKIS, supra note 181, at 16. 
243.  Nancy Touchette, Genome Test Nets Suspected Serial Killer, GENOME NEWS NETWORK 
(June 13, 2003), http://www.genomenewsnetwork.org/articles/06_03/serial.shtml. 
244.  Id. 
245.  DNAPrint Genomics Goes Bust, GENOMEWEB (Mar. 3, 2009), 
http://www.genomeweb.com/node/912684?emc=el&m=325264&l=1&v=e993a10706. 
246.  Touchette, supra note 243. 
247.  Id. 
248.  Id. 
249.  Id. 
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3. The Risks and Benefits of DNA Forensics: The Racial Context of a 
Tarnished Gold Standard 
a. Whose DNA is in the Database? The Relevance of Race 
Genetic technologies have played a key role in both identifying 
suspects and exonerating falsely accused individuals.250 However, Blacks’ 
and Latinos’ routine and disproportionate contact with law enforcement 
provides an important context from which to understand DNA forensics’ 
broader implications for racial minorities and biological understandings of 
racial difference. In a 2008 study by the Pew Center for the States, 
researchers showed that “for the first time, more than one in every 100 
adults is now confined in an American jail or prison.”251 The 2.3 million 
incarcerated American adults outnumber countries with what many 
consider to be more draconian legal systems, such as China (1.5 million 
incarcerated) and Russia (890,000).252 But there is concern not only with 
the number of people in prison, but also the disproportionate incarceration 
of racial minorities. The Pew Study shows that one in 245 Whites are likely 
to be imprisoned at some point in their life compared with one in 41 Blacks 
and one in 96 Hispanics.253 The numbers are even more distressing for 
Black men between twenty and twenty-four, who have a one in 9 chance of 
being incarcerated, and Black men between ages thirty-five and thirty-nine, 
who have a one in 10 chance of being incarcerated.254 Women of color are 
also incarcerated disproportionately. For example, one in 355 White 
women between ages thirty-five and thirty-nine will face incarceration, as 
compared to one in 100 for similarly-aged Black women.255 
These numbers draw attention to law enforcement’s longstanding 
practice of targeting communities of color, particularly as a function of the 
war on drugs.256 These policing practices not only lead to racially 
 
250.  See INNOCENCE PROJECT, 250 EXONERATED: TOO MANY WRONGFULLY CONVICTED (2010), 
available at http://www.innocenceproject.org/docs/InnocenceProject_250.pdf. 
251.  PEW CTR. ON THE STATES, ONE IN 100: BEHIND BARS IN AMERICA 2008, at 3 (2008), 
available at http://www.pewcenteronthestates.org/uploadedFiles/One%20in%20100.pdf. 
252.  Id. at 5. 
253.  Id. at 34. 
254.  Id. 
255.  Id. 
256.  See JUST. POL’Y INST., THE VORTEX: THE CONCENTRATED RACIAL IMPACT OF DRUG 
IMPRISONMENT AND THE CHARACTERISTICS OF PUNITIVE COUNTIES (2007), available at 
http://www.justicepolicy.org/images/upload/07-12_REP_Vortex_AC-DP.pdf. The Justice Policy 
Institute notes that state and federal incarcerations stemming from drug offenses rose 21 percent 
between 1995 and 2003 and that there was a 47 percent increase for those in jail on drug charges during 
this period. Id. at 2. It also notes that “African Americans are disproportionately incarcerated for drug 
offenses in the U.S., though they use and sell drugs at similar rates to whites.” Id. In 2003, African 
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disproportionate numbers in convictions, but also in arrests and 
detainments. They also suggest a similar minority overrepresentation in 
state and federal DNA databases. Although Blacks only make up 13 
percent of the population, it has been estimated that they constitute 40 
percent of the profiles in DNA databases maintained by the federal 
government.257 Racial minorities’ disproportionate representation in DNA 
databases suggests that this technology will increasingly place these 
communities under a new and pervasive form of genetic surveillance. 
These technologies’ shortcoming and overstatements regarding their 
precision258 will undoubtedly have a disproportionate effect on minority 
communities.259 
b. Technical Shortcomings Associated With DNA Forensics 
It is in this context that we can begin to assess DNA forensics’ 
shortcomings to understand how these applications may lead to new forms 
of racial injustice. Each of these technologies has played a significant role 
in identifying and ultimately convicting criminals. Yet, they also have 
significant technical deficiencies that belie the claims of infallibility 
surrounding DNA databases.260 First, the astronomical statistics used to 
suggest the unlikelihood of coincidental matches occurring in DNA 
databases may not be as strong as they initially appear.261 The premise 
behind amassing large DNA databases is that individuals’ profiles across at 
least nine loci are dissimilar enough to only pose an infinitesimally low risk 
for coincidental matches.262 However, recent data from three state 
databases show otherwise. Arizona’s state database of 65,493 offenders had 
122 pairs of profiles matching at nine loci, twenty pairs at ten loci, and two 
pairs of siblings each matching at eleven and twelve loci, respectively.263 
Illinois’s state database of 220,000 profiles had 903 pairs matching at nine 
 
Americans made up 13 percent of the total population, but accounted for more than half of the 
sentenced drug offenders in state prisons. Id. 
257.  Greely et al., supra note 213, at 258. 
258.  See infra Part IV.B. 
259.  See D.H. Kaye & Michael E. Smith, DNA Identification Databases: Legality, Legitimacy, 
and the Case for Population-wide Coverage, 2003 WIS. L. REV. 413, 452–53 (2003). Kaye and Smith 
note that “[a]rrest, prosecution, and conviction are so pervasive in black communities that, on any given 
day, a black American is five times more likely to be in jail than is a white. Id. (internal citations 
omitted). The authors add that, “[w]ithout seismic changes in Americans’ behavior or in the criminal 
justice system, nearly 30% of black males, but less than 5% of white males will be imprisoned on a 
felony conviction at some point in their lives.” Id. 
260.  Jon Jefferson, Cold Hits Meet Cold Facts: Are DNA Matches Infallible?, TRANSCRIPT, 
Spring 2008, at 29, 30–31. 
261.  Id. 
262.  Id. at 32. 
263.  Id. at 32–33. 
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or more loci..264 Maryland’s state database of 30,000 profiles had thirty-two 
pairs matching at nine loci and three matching at all thirteen.265 How do we 
explain this unexpectedly high number of ostensibly unique profiles in the 
same database matching each other? It is not clear, which is why a growing 
number of scientists have requested greater access to government operated 
forensic databases to better understand this problem.266 Thus far, the 
government has declined.267 
The problem of coincidental matches is pressing because the potential 
overestimation of their rarity may lead to false convictions. There are 
significant questions about the appropriate way to express this probability. 
For example, police identified John Puckett in 2004 through a cold hit 
DNA database search in California that matched his profile to crime scene 
evidence from a 1972 murder at 5.5 loci.268 The prosecutor told jurors that 
there was only a one in 1.1 million chance that the match was 
coincidental.269 No other evidence connected Puckett to the crime and he 
was convicted of murder based largely on this cold hit evidence.270 This 
points to a debate about whether general population figures should be used 
as a reference point in calculating these statistics (as they were in the 
Puckett case) or the number of profiles in the relevant database. The 
problem in using general population figures as a reference point is 
explained by William C. Thompson, Professor of Criminology, Law, and 
Society at the University of California, Irvine: 
[S]uppose that a partial DNA profile from a crime scene occurs with a 
frequency of 1 in 10 million in the general population. If this profile is 
compared to a single innocent suspect, the probability of a coincidental 
match is only 1 in 10 million. . . . By contrast, when searching through a 
database as large as the FBI’s National DNA Index System (NDIS), which 
reportedly contains nearly 6 million profiles, there are literally millions of 
opportunities to find a match by coincidence. Even if everyone in the 
database is innocent, there is a substantial probability that one (or more) 
 
264.  Linda Geddes, For Justice, Share DNA Databases, NEW SCIENTIST, Jan. 6, 2010, at 8, 
available at http://www.newscientist.com/article/mg20527424.700-unreliable-evidence-time- to-open-
up-dna-databases.html (under the title “Unreliable Evidence? Time to Open up DNA Databases”). 
265.  Id. 
266.  See D.E. Krane et al., Letter to the Editor, Time for DNA Disclosure, 326 SCI. 1631 (2009). 
267.  See id. 
268.  Jason Felch & Maura Dolan, When a Match Is Far from a Lock, L.A. TIMES, May 4, 2008, 
http://articles.latimes.com/print/2008/may/04/local/me-dna4. 
269.  Id. 
270.  Id. 
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will have the 1-in-10 million profile. Hence, a match obtained in a 
database search might very well be coincidental.271 
If the size of the database is taken into account in Puckett’s case—a 
practice recommended by expert committees convened by the FBI272 and 
National Research Council273 but rarely followed—the probability that the 
database has at least one profile that might coincidentally match the crime 
scene evidence if the assailant’s profile is not present becomes one in 
three.274 
Familial searches also raise significant concerns. Since Black and 
Latino profiles are disproportionately represented in DNA databases, the 
expanded net of suspects created by familial searches is more likely to 
affect extended families in minority communities who may have nothing to 
do with the alleged crimes.275 Familial searching places “a new category of 
people . . . under lifetime genetic surveillance. [DNA databases’] 
composition would reflect existing demographic disparities in the criminal 
justice system, in which arrests and convictions differ widely based on 
race, ethnicity, geographic location, and social class. Familial searching 
potentially amplifies these existing disparities.”276 Racially skewed 
policing practices in the United Kingdom substantiate this concern, where 
“nearly four in 10 black men . . . are on the police’s national [DNA] 
database—compared with fewer than one in 10 white men.”277 As noted 
earlier in this section, a similar racial architecture is evolving in local, state, 
and federal databases in the United States, giving rise to substantial civil 
liberty concerns about the way in which this technology is used. Familial 
searches include greater proportions of minority communities as possible 
suspects because these searches implicate those who are merely related to 
 
271.  THOMPSON, supra note 233, at 10. The one in 1.1 million figure in the Puckett case used the 
population figure as a referent. 
272.  FBI DNA Advisory Bd., Statistical and Population Genetics Issues Affecting the Evaluation 
of the Frequency of Occurrence of DNA Profiles Calculated from Pertinent Population Database(s), 
FORENSIC SCI. COMM., July 2000, available at 
http://www2.fbi.gov/hq/lab/fsc/backissu/july2000/dnastat.htm. 
273.  NAT’L RESEARCH COUNCIL, THE EVALUATION OF FORENSIC DNA EVIDENCE: AN UPDATE 
(1996), available at http://www.nap.edu/openbook.php?record_id=5141. 
274.  Felch & Dolan, supra note 268. See also David Kaye, Taking Liberties With the Numbers, 
SCI. & L. BLOG, April 18, 2009, available at 
http://lawprofessors.typepad.com/science_law/2009/week16/index.html.  
275.  Greely et al., supra note 213, at 258. 
276.  Frederick R. Bieber, Charles H. Brenner & David Lazer, Finding Criminals Through DNA 
of Their Relatives, 312 SCIENCE 1315, 1316 (2006). 
277.  James Randerson, DNA of 37% of Black Men Held by Police, THE GUARDIAN (Jan. 4, 
2006), http://www.guardian.co.uk/world/2006/jan/05/race.ukcrime. 
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someone in the database. Simon Cole, Associate Professor of Criminology, 
Law, and Society at the University of California, Irvine, notes: 
Familial searching exacerbates the discriminatory effects of database 
composition. . . . [I]nclusion of an individual in a database effectively 
adds that individual’s close relatives to the database as well. In the context 
of an arrestee database, in a society in which young African-American 
males have a one in three chance of experiencing some form of state 
custody, this could quickly result in effectively incorporating entire 
neighborhoods and ethnic communities into the database.278 
The concerns with molecular photofitting are similar to those with 
genetic ancestry testing to the extent that they rely upon a similar 
underlying technology of admixture testing; estimations are crude and 
based on databases with significant limitations, are often proprietary, and 
are not routinely subjected to peer review.279 These concerns are amplified 
significantly when moved from the context of recreational genetics to 
criminal investigations. Some geneticists have questioned the underlying 
theory of admixture testing, which is based on assumptions about human 
population structure that are incongruent with mainstream evolutionary 
understandings of human ancestry.280 This raises a profound question at the 
intersection of law and science: Is it appropriate to use a technology to 
identify and convict individuals that is based on a theory that is not fully in 
line with basic Darwinian premises at the heart of modern science? 
By treating racial identity as something that can be measured and 
verified through scientific methods, DNA forensic applications such as 
molecular photofitting play a direct role in reconstituting the biological 
significance of racial difference. But other dynamics such as DNA 
databases’ expanding uses and racially disproportionate composition may 
play a more insidious role in the re-emergence of biological race by 
emphasizing links between race and criminality. This can shape both public 
perceptions and future research agendas in terms of how we understand the 
relationship between race, crime, and genetics. 
 
278.  Simon A. Cole, How Much Justice Can Technology Afford? The Impact of DNA Technology 
on Equal Criminal Justice, 34 SCI. & PUB. POL’Y 95, 102 (2007) (internal citation omitted). 
279.  Bolnick et al., supra note 154, at 400 (discussing shortcomings of admixture testing). 
280.  Kenneth M. Weiss & Jeffrey C. Long, Non-Darwinian Estimation: My Ancestors, My 
Genes’ Ancestors, 19 GENOME RES. 703, 705, 708 (2009) (noting that these tests place “heavy emphasis 
on the idea that the world once harbored distinct and independently evolved populations that have now 
undergone admixture of an unstated type,” despite the fact that this concept of genetic ancestry is “more 
in line with race concepts held by European explorers and traders than with the recent genetic evidence 
supporting the serial sampling model of human evolutionary history”). 
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Sociologist Troy Duster argues that the confluence of these forensic 
applications raises the specter of a twenty-first century phrenology, noting 
that, while “[o]ne could do a SNP profile of rapists and sex offenders, and 
find some markers that they putatively share,” these markers will be 
“precisely that, ‘markers,’ and not explanatory of ‘the causes’ of violent 
crime.”281 Such a proposal would not be unprecedented. In the 1990s, 
several federal administrators proposed a failed plan called the Violence 
Initiative, which was based on two premises: “The first was that much of 
violent behavior in the inner city may have biological or genetic origins. 
The second premise was that ‘factors of individual vulnerability and 
predisposition to violent behavior exist—factors that may be detected at an 
early age.’”282 Frederick Goodwin, then head of the Alcohol, Drug Abuse, 
and Mental Health Administration and Violence Initiative noted in a 1992 
address that the Initiative’s purpose was to “design and evaluate 
psychosocial, psychological, and medical interventions for at-risk children 
before they become labeled as delinquent or criminal. This is the basic 
point of it all . . . identifying at-risk kids at a very early age before they 
have become criminalized.”283 Given that today’s DNA databases function 
as an existing repository of what many consider to be criminal genes, future 
research linking genes and criminal outcomes is not far-fetched. Nor is it 
far-fetched to think that these databases’ racially disproportionate 
composition will place race at the center of this discussion. 
IV. TOWARD RACE IMPACT ASSESSMENTS 
A. THE PERSISTENCE OF TYPOLOGICAL THINKING ABOUT RACE IN 
SCIENCE 
Race-based medicines, genetic ancestry tests, and DNA forensics can 
each potentially benefit racial minorities and society in general by 
providing life-saving medicines targeted for vulnerable and underserved 
populations, increasing individuals’ knowledge about their ancestry, and 
 
281.  Troy Duster, Selective Arrests, An Ever-Expanding DNA Forensic Database, and the 
Specter of an Early-Twenty-First Century Equivalent of Phrenology, in DNA AND THE CRIMINAL 
JUSTICE SYSTEM: THE TECHNOLOGY OF JUSTICE 315, 315 (David Lazer ed., 2004). 
282.  Vernellia R. Randall, Slavery, Segregation and Racism: Trusting the Health Care System 
Ain’t Always Easy! An African American Perspective on Bioethics, 15 ST. LOUIS U. PUB. L. REV. 191, 
227 (1996). 
283.  Garland E. Allen, Modern Biological Determinism: The Violence Initiative, the Human 
Genome Project, and the New Eugenics, in THE PRACTICES OF HUMAN GENETICS 1, 1 (Michael Fortun 
& Everett Mendelsohn eds., 1999) (quoting Frederick K. Goodwin, Conduct Disorder as A Precursor to 
Adult Violence and Substance Abuse: Can the Progression be Halted, Address to the American 
Psychiatric Association (May 5, 1992)). 
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offering tools to law enforcement to help solve crimes. However, these 
technologies are also united by a tendency to promote typological 
perspectives on race that are reminiscent of the nineteenth and early 
twentieth centuries when “pure” or “real” races were thought to 
independently exist and each race was thought to share a set of unique 
biological traits that could be identified and measured.284 This contrasts 
with mainstream scientific perspectives that view the distribution of human 
traits on a continuum that does not have the discrete breaks that typologists 
find indicative of biological race.285 
Despite this tension, biological race continues to be salient in lay and 
scientific discourses. Increasing public exposure to race and genetics 
research is shaping lay opinions about the relevance of genes to racial 
disparities in social and health outcomes.286 At the same time, scientists 
continue to espouse typological approaches that give coherence to 
biological understandings of racial difference. Sociologist Ann Morning, 
who has conducted research on scientists’ perspectives on race, observes 
that: 
[S]ocial and biological scientists hold a wide range of beliefs about the 
nature of racial difference; contrary to some scholars’ expectations, they 
are far from any consensus, either within or between disciplines. . . . [T]he 
essentialist proposition that races are biologically grounded entities 
remains a compelling view for many contemporary scientists.287 
This all leads to an important question: Given law’s past complicity in 
furthering racial subordination through promoting biological race, what 
normative role should government take in regulating new biotechnologies 
that advance biological understandings of racial difference? This is a 
difficult question because the social and scientific contexts have changed 
between past articulations of biological race and today’s innovations, but 
the potential risks to racial minorities remain quite similar. While overly 
strict regulations might unduly prevent access to life-saving or life-
enhancing technologies, overly permissive approaches may lead to new 
 
284.  Ernst Mayr, Typological Versus Population Thinking, in CONCEPTUAL ISSUES IN 
EVOLUTIONARY BIOLOGY 325, 327 (Elliott Sober ed., 3d ed. 2006) ( “The typologist stresses that every 
representative of a race has the typical characteristics of that race and differs from all representatives of 
all other races by the characteristics ‘typical’ for the given race. All racist theories are built on this 
foundation. Essentially, it asserts that every representative of a race conforms to the type and is 
separated from the representatives of any other race by a distinct gap.”). 
285.  See id. at 326–28. 
286.  See generally, Celeste M. Condit et al., The Role of “Genetics” in Popular Understandings 
of Race in the United States, 13 PUB. UNDERSTANDING OF SCI. 249 (2004). 
287.  ANN MORNING, THE NATURE OF RACE: HOW SCIENTISTS THINK AND TEACH ABOUT 
HUMAN DIFFERENCE 221 (2011). 
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forms of racial subordination and promote an impoverished understanding 
of race among the public. 
B. REGULATORY GULF: EXPANDING USES, DIMINISHING OVERSIGHT 
Biotechnologies that implicate race are expanding in their use and 
development. For example, biologists Sarah Tate and David Goldstein 
observed in a 2004 Nature Genetics article that, while controversial, “[a]t 
least 29 medicines (or combination of medicines) have been claimed, in 
peer-reviewed scientific or medical journals, to have differences in either 
safety or, more commonly, efficacy among racial or ethnic groups.”288 This 
suggests that more race-based medicines such as BiDil are in development 
and may very well be on their way.289 Additionally, genetic ancestry tests 
are also becoming increasingly popular. Bolnick and several colleagues 
note that “[a]t least two dozen companies now market ‘genetic ancestry 
tests,’ . . . [and that m]ore than 460,000 people have purchased these tests 
over the past 6 years, and public interest is still skyrocketing.”290 Most 
recently, scholar Henry Louis Gates Jr. and others joined 23andMe as 
advisors to the direct-to-consumer genetics company’s “Roots into the 
Future” program, which hopes to attract 10,000 African Americans to its 
ancestry testing services.291 
New applications of DNA forensics are probably expanding the 
fastest. For example, Murphy notes that while  
it took Virginia nearly eight years, from 1993 to 2001, to reach its first 
1,000 ‘cold hits,’ the state reached its second 1,000 in a matter of eighteen 
months. Since 2001, the laboratory has averaged at least one ‘cold hit’ a 
day, and as of July 2002, that figure had doubled to two and one half hits 
a day.292  
 
288.  Sarah K. Tate & David B. Goldstein, Will Tomorrow’s Medicines Work for Everyone?, 36 
NATURE GENETICS SUPP. S34, S34 (2004). They then note that “these claims are universally 
controversial and there is no consensus on how important race or ethnicity is in determining drug 
response.” Id. 
289.  For an example of ongoing research on race-based pharmacogenomics, see Jieming Chen et 
al., Interethnic Comparisons of Important Pharmacology Genes Using SNP Databases: Potential 
Application to Drug Regulatory Assessments, 11 PHARMACOGENOMICS 1077 (2010). 
290.  Bolnick et al., supra note 154, at 399. 
291.  According to 23andMe’s announcement of the project, Roots into the Future will “help 
determine how genetic factors contribute to the development of disease in this population,” and “aligns 
with 23andMe’s broader mission of empowering individuals to understand their own genetic data.” 
23andMe, Roots into the Future: A New 23andme Research Initiative for African-Americans, SPITTOON 
(July 26, 2011, 5:00 AM), http://spittoon.23andme.com/2011/07/26/roots-into-the-future/. Those who 
participate in the project will receive “free access to their personal genetic data used for the research, as 
well as health and ancestry interpretations of the data.” Id. 
292.  Murphy, supra note 232, at 740. 
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Applications such as molecular photofitting are being developed to achieve 
higher levels of sophistication, while practices like familial testing are 
becoming increasingly commonplace in criminal investigations.293 For 
example, the California Attorney General’s office has issued guidelines for 
familial testing for its state database,294 which will likely accelerate the use 
of this technology by state and local law enforcement.295 
At the same time that these technologies are expanding, regulatory 
oversight of their scientific rigor and public impact remains inadequate. 
The FDA does not subject new drug applications seeking race-specific 
labeling to any other standard outside the agency’s traditional emphasis on 
safety and efficacy.296 Direct-to-consumer genetic tests have been criticized 
by some federal agencies including the FTC,297 but the specific issues 
related to race and genetic ancestry have not been a significant part of the 
conversation. Genetic ancestry tests fall outside of the FDA’s regulatory 
authority because “[a] genetic test is only subject to FDA oversight if it is a 
medical device . . . whereas a test to determine ancestry is not a device.”298 
Moreover, the FBI, in coordination with state and local law enforcement 
agencies, continues to expand DNA forensics into questionable areas such 
as familial testing and molecular photofitting. These applications can 
 
293.  See supra Part III.C.2.b. 
294.  See Information Bulletin from Lance Gima, Chief, Bur. Forensic Svcs. & Edmund G. 
Brown, Jr., Cal. Att’y Gen. to All Cal. Law Enforcement Agencies & Dist. Atty’s Offices, DNA Partial 
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295.  See Maura Dolan, State to Double Crime Searches Using Family DNA, L.A. TIMES (May 9, 
2011), http://www.latimes.com/news/local/la-me-familial-dna-20110509,0,3088333,full.story. 
296.  See Winickoff & Obasogie, supra note 29, at 278 (arguing that “the FDA should deploy a 
heightened standard of efficacy when approving race-specific indications”). 
297.  See At Home Genetic Tests: A Healthy Dose of Skepticism May Be the Beset Prescription, 
FEDERAL TRADE COMMISSION (July 2006), 
http://www.ftc.gov/bcp/edu/pubs/consumer/health/hea02.shtm. In a notice to consumers, the FTC 
wrote: 
According to the Food and Drug Administration (FDA), which regulates the manufacturers 
of genetic tests; and the Centers for Disease Control and Prevention (CDC) . . . some of 
these tests lack scientific validity, and others provide medical results that are meaningful 
only in the context of a full medical evaluation. The FDA and CDC say that because of the 
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298.  Jeffrey Shuren, Dir., Ctr. for Devices & Radiological Health, F.D.A. Statement Before the 
U.S. House of Representative Subcommittee on Oversight and Investigations Committee on Energy and 
Commerce: Direct-to-Consumer Genetic Testing and the Consequences to the Public (July 22, 2010), 
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significantly impact minority communities, as well as alter public 
understandings of race.299 Therefore, a more robust regulatory response is 
needed to ensure that these innovations do not legitimize biological 
understandings of race in a manner that supersedes their potential benefits. 
C. EXISTING PROPOSALS 
While the issue of race and genetics has received substantial attention 
from legal scholars, there have been relatively few proposals for how law 
can balance the benefits and potential harms of human biotechnologies that 
implicate race. Scholars have attempted to provide broad regulatory 
guidance for how racial categories should be used in human biotechnology 
beyond the various federal mandates that require the inclusion of minorities 
in clinical trials.300 For example, Dorothy Roberts assesses various legal 
constraints on race-based research—including regulations on federally-
funded research, civil rights statutes, and state laws—to suggest a social 
justice framework based upon Equal Protection norms.301 This social 
justice approach “explore[s] how the law might seriously enforce the view 
that race is an unscientific and pernicious classification of human beings at 
the same time that systemic racism produces health inequities.”302 Law 
professor Jonathan Kahn similarly draws on Equal Protection norms to 
propose a series of guidelines for how and when scientists use social 
categories of race in connection with biomedical research.303 He argues for 
requiring “a tight fit (a) between the population, racial/ethnic, and genetic 
categories being used and (b) between the genetic category identified and 
the disease state/health issue or other biological activity being analyzed.”304 
Law professors Erik Lillquist and Charles Sullivan offer a comprehensive 
examination of existing legal regimes to discuss various constraints 
associated with using race in biomedical research.305 They argue that 
“[r]acial differences in treatment (including diagnostic screening) should be 
permissible only in rare circumstances where there is a bona fide treatment 
rationale . . . [and] race [is] the best available method at the time.”306 In 
assessing the Court’s colorblind norms in its Equal Protection 
jurisprudence, law professor Kimani Paul-Emilie develops the notion of 
 
299.  See supra Part III.C.2.b. 
300.  Kahn, Genes, Race, and Population, supra note 29, at 7 (internal citation omitted). 
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“racial pragmatism” to find a set of residual guidelines for when the 
government may appropriately take race into consideration in biomedical 
research.307 My own work in this area employs the notion of strict scrutiny 
found in Equal Protection law to develop oversight mechanisms for drugs 
seeking race-specific indications,308 and also to set a standard of review for 
FDA advisory committees.309 
Each of these proposals offers significant insight on how to fill the 
remarkable gap in regulatory oversight regarding race and human 
biotechnology. However, at least two characteristics may lead these efforts 
to not be fully responsive to existing challenges. First, existing proposals 
for greater oversight of new genetic technologies that implicate biological 
race tend to focus on biomedicines without examining how these issues 
play out in other realms—most notably, genetic ancestry tests and DNA 
forensics. Taken together, race-based medicines, ancestry tests, and DNA 
forensics have synergistic effects that are much greater than the individual 
applications, yet the trend is to analyze each application in isolation. By 
failing to develop regulatory mechanisms that approach the race and 
genetics issue holistically in terms of the multiple sites where these 
technologies can recreate notions of biological race, existing proposals may 
not be able to have their intended impact. Second, these proposals tend to 
look to existing laws—especially Equal Protection jurisprudence—for a 
source of normative guidelines from which to abstract and apply to the 
emerging and quickly changing area of race and human biotechnology. 
This approach has limitations, as it looks backward and sideways to how 
law has treated race to think prospectively and normatively about how 
regulators ought to oversee these technologies. This approach lacks the 
flexibility to adjust to fundamentally different contexts and claims 
connected to these technologies. What is needed is not only normative 
guidelines, but also a deliberative space where we can fluidly discuss 
oversight mechanisms, specific challenges raised by new technologies, and 
the technologies’ impact on certain communities. 
 
307.  Paul-Emile, supra note 29. 
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309.  For my argument that advisory committees should use a “strict scrutiny framework” to 
review new drugs that propose race-specific indications, see Osagie K. Obasogie, Beyond Best 
Practices: Strict Scrutiny as a Regulatory Model for Race-Specific Medicines, 36 J.L. MED. & ETHICS 
491, 496 (2008). 
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D. THE NEED FOR ADMINISTRATIVE AGENCY IMPACT ASSESSMENTS ON 
RACE AND HUMAN BIOTECHNOLOGY 
Each application discussed in this Article falls under the 
administrative authority of an existing government agency that can set 
standards for how the public engages these innovations: the FDA for race-
based medicines, the FTC for genetic ancestry tests, and the FBI for DNA 
forensics. As discussed earlier in this section, existing regulatory 
approaches to these applications by these agencies are thin; race simply is 
not taken seriously as a regulatory matter despite the potential risks that 
these applications portend for reinventing biological race in a manner that 
may disadvantage minorities. 
To avoid these risks and to give minorities access to potential benefits 
that may stem from these technologies, I propose race impact assessments 
as a new tool for administrative agencies that are responsible for overseeing 
any new biotechnology that implicitly or explicitly makes a claim about the 
biological significance of social categories of race, or that may 
disproportionately affect minority communities. Generally, impact 
assessments are evaluative mechanisms used by government agencies to 
analyze the risks and benefits of new proposals so as to promote individual 
and social well-being. Most notably, environmental impact assessments 
have played a significant role in making sure that government agencies 
consider the potential consequences that a new project or initiative might 
have on the environment before moving forward.310 The National 
Environmental Policy Act (“NEPA”), signed into law in 1970,311 requires 
federal agencies to determine whether certain proposed actions—road 
construction, building construction, etc.—might have an adverse effect on 
the human environment.312 NEPA’s most significant legal requirement is 
 
310.  Impact assessments have been used widely in environmental studies, where environmental 
impact assessments have been used to analyze “the environmental implications of a decision to enact 
legislation, to implement policies and plans, or to initiate development projects.” Peter Wathern, An 
Introductory Guide to EIA, in ENVIRONMENTAL IMPACT ASSESSMENT: THEORY AND PRACTICE 3, 3 
(Peter Wathern ed., 1998). However, this Article focuses on the use of impact assessment in analyzing 
issues that directly affect human social, legal, or health outcomes. 
311.  National Environmental Policy Act of 1969, Pub. L. No. 91-190, 83 Stat. 852 (codified as 
amended at 42 U.S.C. §§ 4321, 4331–35, 4341–47 (2012)). 
312.  NEPA requires agencies to “include in every recommendation or report on proposals for 
legislation and other major federal actions significantly affecting the quality of the human environment” 
an environmental impact statement. 42 U.S.C. § 4332(C). These statutory requirements have been 
defined within the Code of Federal Regulations. 40 C.F.R. § 1502.3. For specific definitions, see § 
1508.23 (defining “on proposals”), § 1508.17 (defining “for legislation”), § 1508.18 (defining “other 
major federal actions”), § 1508.27 (defining “significantly”), §§ 1508.3, 1508.8 (defining “affecting” 
and “effects”), and § 1508.14 (defining “the quality of the human environment”). 
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the Environmental Impact Statement (“EIS”).313 Generally, agencies will 
first conduct an initial environmental assessment.314 This initial assessment 
determines if a proposed action might have an adverse effect on the human 
environment that requires an EIS.315 The more rigorous EIS process seeks 
to flesh out the potential harms of a proposed action and determine if viable 
and less disruptive alternatives exist.316 According to 40 C.F.R § 1502.1, 
the purpose of an EIS is to “serve as an action-forcing device to insure that 
the policies and goals defined in the Act are infused into the ongoing 
programs and actions of the Federal Government.”317 Brian Cole and his 
co-authors note that “[t]he authors of NEPA recognized . . . that [the] 
problems in one sector are shaped to a large extent by actions in other 
sectors[,] . . . [whereby] the assessment and consideration of environmental 
impacts has become a routine part of decision making in federal, state, and 
local agencies.”318 Thus, the major achievement of environmental impact 
assessments has been to change the culture of administrative agencies by 
raising awareness and improving sensitivity to the way that federal actions 
can damage the environment and to the crucial role that regulatory agencies 
can play in mitigating these harms. 
Much of this cultural change has occurred through the 
interdisciplinary and cooperative nature of environmental impact 
assessments as dictated by federal law.319 By simultaneously engaging in 
prospective assessment of potential impacts and making these findings 
publically available for comment and feedback, environmental impact 
statements have been able to institutionalize environmental concerns and an 
ethos of public engagement into regulatory agencies’ organizational 
behavior.320 In doing this, NEPA and its environmental impact statements 
 
313.  42 U.S.C. § 4332(C)(i). 
314.  40 C.F.R. § 1508.9. 
315.  Id. Some proposals may not require an initial environmental assessment or an EIS if they fall 
into a categorical exclusion or “a category of actions which do not individually or cumulatively have a 
significant effect on the human environment.” Id. § 1508.4. Other proposals may not require an EIS if 
after an environmental assessment, agencies conclude with a “finding of no significant impact.” Id. 
§ 1508.13. 
316.  42 U.S.C. § 4332(C)(i)–(iv). 
317.  40 C.F.R. § 1502.1. 
318.  Brian L. Cole et al., Prospects for Health Impact Assessment in the United States: New and 
Improved Environmental Impact Assessment or Something Different?, 29 J. HEALTH POL. POL’Y & L. 
1153, 1157 (2004). 
319.  40 C.F.R. § 1502.6 (2012) (stating that “[e]nvironmental impact statements shall be prepared 
using an inter-disciplinary approach which will insure the integrated use of the natural and social 
sciences and the environmental design arts”). 
320.  Serge Taylor notes that: 
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have led to better “integration of environmental goals into agency decision 
making, improved planning, and transparency and public involvement for 
improved agency decision making.”321 These successes have led to impact 
assessment proposals in other areas of federal oversight. For example, 
health impact assessments (“HIAs”) have been proposed to identify 
activities and policies “likely to have major impacts on the health of a 
population in order to reduce the harmful effects on health and to increase 
beneficial effects.” 322 HIAs evaluate the potential health impacts of a 
proposal based on “a broad model of health, which proposes that economic, 
political, social, psychological, and environmental factors determine 
population health,” and take into consideration the “opinions and 
expectations of those who may be affected by a proposed policy.”323 
Scholars have proposed other types of impact assessments that draw on 
these themes. For example, social impact assessments have been developed 
as a way to “analy[ze] . . . and manag[e] the intended and unintended 
consequences on the human environment of interventions . . . and social 
change processes so as to create a more sustainable biophysical and human 
environment.”324 Similarly, human rights impact assessments have been 
suggested to “help evaluate the effects of public health policies on human 
rights and dignity.”325 
Impact assessments of this nature share at least three relevant 
characteristics that are informative for developing race impact assessments. 
First, impact assessments are evidence-based; data collection is central to 
the regulatory decision-making process. No one type of data is privileged; 
 
“[b]efore the National Environmental Policy Act, most federal agencies paid scant attention 
to environmental values. Since the advent of NEPA, environmental concerns have been 
officially incorporated into every agency’s charter. . . . [W]hen the inside analysts are able to 
explore the possible environment-development trade-offs of a wide range of alternative 
designs, environmentally better decisions are likely to result: all projects benefit from 
relatively inexpensive environmental mitigation. When in addition, environmentally 
concerned outsiders pay attention to the EIS process, some of the worst projects – those 
projects with the greatest environmental costs and little political support within the agency 
and among its other constituents – get eliminated.” 
SERGE TAYLOR, MAKING BUREAUCRACIES THINK: THE ENVIRONMENTAL IMPACT STATEMENT 
STRATEGY OF ADMINISTRATIVE REFORM 251 (1984) 
321.  Cole et al., supra note 318, at 1167–68. 
322.  N. & Y. PUB. HEALTH OBSERVATORY., AN OVERVIEW OF HEALTH IMPACT ASSESSMENT 1 
(2001), available at http://dro.dur.ac.uk/5613/1/5613.pdf. 
323.  Id. 
324.  Frank Vanclay, Social Impact Assessment 2 (World Comm. On Dams, Working Paper, 
2000), available at http://www.scribd.com/doc/81829611/Social-Impact-Assessment-Vanclay. 
325.  Lawrence Gostin & Jonathan M. Mann, Towards the Development of a Human Rights 
Impact Assessment for the Formulation and Evaluation of Public Health Policies, 1 HEALTH & HUM. 
RTS. 59, 60 (1994). 
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impact assessments can be quantitative or qualitative. These assessments 
place a premium on engaging with, and thinking through, various policy 
proposals’ real-world implications. As a second related trait, impact 
assessments are multidisciplinary. Just as no one type of data is privileged, 
neither is any one disciplinary approach. To be sure, the strength of impact 
assessments stem from their use of multiple methods and multiple 
disciplinary perspectives so as to provide a holistic analysis of the many 
ways in which health, society, human rights, or any other issue may be 
affected by a particular proposal. Third, impact assessments are 
characterized by involving multiple stakeholders. While many of the issues 
analyzed by impact assessments are highly technical and deeply embedded 
in cutting-edge science, impact assessments are used to bring a wide range 
of people—experts, non-experts, community members, and others—in a 
deliberative and collaborative effort to ensure that decision makers are 
informed of all perspectives.326 
These fundamental characteristics of impact assessments produce at 
least three significant benefits. First, impact assessments help root-out 
facially innocuous practices that may have harmful effects. By being 
sensitive to topics such as the environment, health, or human rights and 
how federal decision making can affect them, policy makers can anticipate 
and mitigate unintended harms—especially those affecting vulnerable 
populations. A second benefit is that impact assessments increase 
cooperation and deliberation between government agencies, experts, and 
the public. The enhanced contact and communication between these 
various stakeholders encourages a more deliberative democracy by creating 
a process involving multiple levels of engagement and accountability.327 
Third, the collaborative effort facilitated by impact assessments encourages 
multiple government agencies to engage with one another about their 
shared responsibilities. This decreases the likelihood of important issues 
falling in between regulatory gaps where agencies can end up pointing the 
finger at each other. 
These traits and benefits suggest that the implementation of race 
impact assessments would significantly assist administrative agencies in 
predicting the risks and benefits of biotechnologies that implicate race so as 
 
326.  “Involving stakeholders has been recommended as essential for building interest in a project 
and promoting the potential use of the results. It is important to involve stakeholders from an early stage 
in the project to promote ownership.” J. Mindell et al., Enhancing the Evidence Base for Health Impact 
Assessment, 58 J. EPIDEMIOL. & CMTY. HEALTH 546, 548 (2004). 
327.  See, e.g., AMY GUTMAN & DENNIS THOMPSON, WHY DELIBERATIVE DEMOCRACY? (2004); 
AMY GUTMAN & DENNIS THOMPSON, DEMOCRACY AND DISAGREEMENT (1996). 
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to mitigate the former and promote the latter. Not only do race impact 
assessments provide an opportunity for a broad appraisal of the scientific 
claims made by race-based medicines, genetic ancestry tests, and DNA 
forensics, but they also provide a forum where multiple stakeholders—such 
as government officials, scientists, constituency based groups, and others—
can exchange ideas. These stakeholders will be able to provide guidance on 
how the public can gain access to biotechnologies’ potential benefits 
without unduly subjecting racial minorities to the risks associated with 
government reasserting questionable linkages between race and biology. 
Impact assessments are not entirely unproblematic.328 For example, 
the assessment process can be quite lengthy and take several years. This is 
particularly troublesome with regards to potentially lifesaving medicines or 
law enforcement practices that can solve open cases and prevent future 
crimes. Second, impact assessments are resource-intensive and can be 
costly. Who is going to pay for these assessments and who has time outside 
of their regular professional and daily obligations to participate in another 
round of bureaucratic fact-finding? In addition to these hurdles, there is 
also a concern that, without any substantive or normative claims supporting 
them, impact assessments can become a mere procedural tool that may not 
be able to create the change they seek. The impact assessment process may 
be vulnerable to co-optation by contrary interests that may work against the 
very concerns giving rise to the assessment process itself and further 
legitimize questionable and unquestioned practices. 
These are surely important concerns. But they are not insurmountable, 
given the remarkable stakes at hand. The unchecked proliferation of 
biological race has been at the center of some of the most brutal acts in 
human history. While those who promote new biotechnologies that 
implicate race often have laudable objectives, it is important to remain 
aware of the possible dangers. Given the government’s historical 
complicity in promoting biological race in a manner that harmed the most 
vulnerable members of society,329 it has a moral and ethical responsibility 
to support race impact assessments to atone for past wrongs and to promote 
a future where minorities can partake in the benefits of scientific innovation 
without remaining perpetually vulnerable to its risks. Moreover, while the 
risk of co-optation is real, improving and diversifying deliberations while 
 
328.  For an extended discussion of the challenges associated with environmental impact 
assessments, see Cole et al., supra note 318, at 1169. 
329.  See supra Part II. 
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making the process more transparent—practices embedded in the impact 
assessment process—can be effective checks. 
E. MODELING RACE IMPACT ASSESSMENTS: INITIAL FRAMING AND 
FUTURE DIRECTIONS 
This Article’s aim and scope are purposefully modest in that I have 
only sought to (1) identify biological race as a historical concern with 
contemporary significance; (2) describe the ways that the State has 
promoted biological race to the detriment of vulnerable populations; (3) 
highlight the reemergence of biological race through the development of 
new biotechnologies; (4) identify the current regulatory gaps that may 
inadvertently give renewed legitimacy to biological race and its harmful 
ideologies; and (5) propose administrative agency race impact assessments 
as a tool to balance the potential risks and benefits of new biotechnologies 
that implicate race. It would be premature to propose a full race impact 
assessment model at this point; successful impact assessments need to 
develop out of robust empirical examinations of each agency’s 
organizational design and culture in relation to current decision making 
processes on race related innovations—information that is not yet fully 
available. Moreover, mature impact assessments require the collaboration 
of experts across multiple fields and affected stakeholders to create model 
tools that balance new technologies’ potential benefits with the potential 
risks of reifying social categories of race as biologically significant lines of 
human difference. However, it may be productive to sketch the next steps 
that need to be taken to move this conversation forward while also broadly 
mapping the ways in which race impact assessments might be integrated 
into federal agencies as part of their review of new technologies that 
implicate race. 
As an initial matter, it is important to note that, before any agency 
moves forward with an assessment of this nature, it would need some type 
of statutory authority—like NEPA—from which to proceed. NEPA 
provides an excellent model that Congress can mimic to charge federal 
agencies to engage in holistic assessments of projects, innovations, or 
proposals that fall under their administrative authority that may potentially 
harm race relations by promoting biological understandings of racial 
difference and disparities. Like the environment, race can be seen as a 
shared and connected ecosystem that requires federal protection for the 
benefit of human health and social relations. Moreover, just as NEPA 
established a Council on Environmental Quality (“CEQ”) within the 
Executive Branch to assist the President in overseeing NEPA’s 
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implementation across federal agencies,330 so too could a similar council 
within the Executive Branch play a key role regarding racial issues.331 This 
council could monitor the diverse ways in which race may be implicated in 
administrative agency decisionmaking—from new drug applications to 
innovative forensic technologies—and encourage consistency across 
federal administrative agencies. 
Creating this statutory authority is an important first step to making 
race impact assessments a viable tool for administrative agencies seeking 
further guidance on how to assess claims pertaining to the biological 
significance of race. Like NEPA, the point of this statutory language is not 
to compel federal agencies to take certain pre-determined actions.332 
Rather, it is to institutionalize a process within administrative agencies that 
gives policymakers and bureaucrats the opportunity to pause, think about 
the racial implications of their actions, engage outside experts and 
community stakeholders as part of the data collection process, and to use 
the results of these consultations and assessment tools to inform whatever 
final decision they might come to. Thus, the goal of race impact 
assessments is not to say that race can never be used in new innovations 
regarding human biotechnology. Instead, it is simply to say that we should 
think clearly about its use so as to avoid applications that uncritically reify 
race as a biological trait when all available evidence suggests approaching 
this trend with skepticism. 
To the extent that each administrative agency has a distinct history, 
organizational structure, and awareness of how race impacts their 
regulatory authority, much more work is needed to determine the most 
productive way to develop and incorporate race impact assessments into 
each agency’s decision making process. Since the directives and decision-
making structures are fundamentally different in the FDA, FTC, and FBI, 
there is no one-size-fits-all race impact assessment tool that can be 
imported into each agency to address these matters. Before impact 
 
330.  42 U.S.C. §§ 4342–4347 (2012). 
331.  In the environmental context, the CEQ’s regulations “set the standard for NEPA 
compliance.” B. Nepa Regulations, NATIONAL ENVIRONMENTAL POLICY ACT, 
http://ceq.hss.doe.gov/welcome.html (last visited Dec. 2, 2012). In addition, the CEQ requires that 
agencies create their own procedures for implementing NEPA, and makes sure that these procedures 
“meet the CEQ standard while reflecting each agency's unique mandate and mission.” Id. 
332.  “[T]here is no substantive requirement forcing federal agencies to select a course of action 
that an [environmental impact statement] identifies as environmentally preferable. The purpose of an 
EIS is to inform agency decision making by identifying probable environmental impacts and making 
this information . . . available for public scrutiny and debate.” Cole et al., supra note 318, at 1161 
(internal citation omitted). 
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assessment tools can be created and implemented, there needs to be a 
careful empirical assessment that maps the ways in which race issues have 
historically been treated within each agency, the existing mechanisms or 
procedures (if any) used to examine the legitimacy of race specific claims, 
and how existing or pending innovations in each field might interact with 
current regulatory assessments. As a more qualitative assessment, 
significant field work (such as interviews or focus groups with employees) 
regarding organizational dynamics and existing procedures for discussing 
race will help locate the opportunities and challenges associated with 
institutionalizing an ethos of race sensitivity both within each agency and 
across all relevant federal agencies. 
These future projects need to be undertaken before robust race impact 
assessment models can be developed. This Article reserves a more detailed 
articulation of the substance and integration of race impact assessments 
into administrative agencies until future research can lay the 
aforementioned empirical groundwork. But for now, it is useful to briefly 
sketch the work that race impact assessments might do. Take, for example, 
a hypothetical new drug not unlike BiDil, where the manufacturer seeks a 
race-specific indication for Latinos with renal disease based on impressive 
clinical trial results with participants that self-identify as Latino. An FDA-
led race impact assessment might begin by identifying relevant 
stakeholders to participate in not only analyzing the claims’ scientific merit 
and clinical trial results, but also the impact that this particular race-specific 
indication might have on racial minorities. This would be balanced with the 
potential benefit produced by the race-specific indication, such as the 
ability to identify and treat more Latinos suffering from this condition or to 
increase compliance within this group. Multiple methods would be used to 
evaluate the evidence—both the statistical assessment of clinical trial data 
and the qualitative assessment of constituent perspectives. A final report 
would be presented to FDA officials to aid their determination of whether a 
race-specific indication is warranted for the drug. 
The FTC might engage in a similar process to assess products 
claiming to use genetic technologies to determine individuals’ racial 
backgrounds. A diverse committee of experts—from population geneticists 
to legal scholars and philosophers—in addition to laypersons would 
examine the claims in relation to the strength and limitations of the 
company’s methods and data. The committee would also collect and assess 
qualitative data from affected stakeholders to analyze the ways this 
technology might affect certain communities and how the public perceives 
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the biological relevance of race. The committee would then provide a 
report to FTC officials to inform their decision about how to oversee the 
sale and marketing of these products. 
The FBI could also use race impact assessments to examine the 
implications of emerging forensic techniques that may disproportionately 
affect minority communities. Not only would an external, quantitatively-
driven scientific evaluation of techniques help assess whether the race-
based or race-impacting methods are valid, but a qualitative assessment of 
stakeholder sentiments might also help the FBI develop procedures that 
both assist them in law enforcement and respect community concerns. 
V. CONCLUSION 
When the first draft of the human genome was completed in 2000 and 
showed that all humans are 99.9 percent similar at the molecular level,333 
scientists, politicians, and the media rejoiced in declaring that there are no 
biological differences between racial groups, not unlike the way biological 
race was publically discredited after World War II.334 President Bill 
Clinton summed up the sentiment in a statement made from the East Room 
of the White House when he pronounced that “modern science has 
confirmed what we first learned from ancient fates. The most important 
fact of life on this Earth is our common humanity.”335 
However, just as biological race remained a salient, if not prominent, 
variable in scientific research after the 1950 UNESCO statement publicly 
declared its death,336 so too has it remained a powerful lens through which 
we understand human difference in the genomic era. Rather than focusing 
on our shared humanity, researchers have focused intensely on the less than 
1 percent of genetic variation thought to explain racial difference and 
disparities. 
There may very well be important innovations emerging from this 
renewed focus on biological race. But, given the horrific track record that 
 
333.  See Nicholas Wade, READING THE BOOK OF LIFE: Now, the Hard Part: Putting the 
Genome to Work, N.Y. TIMES, June 27, 2000, at F1. Subsequent research has revised this figure to 
around 99.5 percent. See generally, Samuel Levy et al., The Diploid Genome Sequence of an Individual 
Human, 5 PLOS BIOLOGY 2113 (2007). 
334.  See supra Part II.C. 
335.  Bill Clinton, Pres. U.S., Tony Blair, P.M. Eng., Dr. Francis Collins, Dir. Nat’l Human 
Genome Research Inst. & Dr. Craig Venter, Pres. & Chief Sci. Officer Celera Genomics Corp., 
Remarks on the Completion of the First Survey of the Entire Human Genome Project (June 26, 2000), 
available at http://www.ornl.gov/sci/techresources/Human_Genome/project/clinton2.shtml. 
336.  See supra Part II.C. 
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we have with using science to measure and define racial difference, the 
government needs to take strong steps to ensure that these technologies are 
used responsibly. Administrative agency race impact assessments are an 
important first step to providing a democratic, deliberative, and 
collaborative space to collect and analyze the data necessary to inform 
decision makers on how to sensibly regulate these new innovations. 
 
